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Abstract 
Ghrelin (GRLN), Cholecystokinin (CCK) and the Neuropeptide Y (NPY) family member; 
PYY are gastrointestinal (GI) tract peptide hormones involved in the optimization of the 
digestive process and regulation of appetite in mammals. Although the functions of these 
hormones have been extensively studied in higher vertebrates, less is known for fish. The high 
diversity between fish species, suggest a species specific approach when studying the role of 
GI tract peptide hormones. Two isoformes of GRLN (GRLN-1, GRLN-2) and CCK (CCK-L, 
CCK-N), in addition to PYY were recently cloned and characterized in Atlantic salmon. 
However, no information is available on the postprandial involvement of these peptide 
hormones in Atlantic salmon GI tract. Therefore an experiment was initiated where the aim 
was to increase the knowledge of regulation of the digestive process and appetite by these key 
GI tract peptide hormones in Atlantic salmon.  
This study describes the spatial distribution and postprandial changes in GRLN, CCK and 
PYY mRNA expression in the GI tract during the complete processing of a single meal in 
Atlantic salmon (average body weight: 44.7 ± 2.1 g). The mRNA expression values were 
obtained by quantitative PCR from four GI tract segments covering stomach, pyloric cecae, 
midgut and hindgut. In order to assess the GI tract transit, the content of feed and chyme in 
each GI tract segment, and gallbladder content were assessed. Unfed fish were used as 
control, and these fish were also used to assess potential diurnal patterns of GRLN-1, GRLN-
2, CCK-L, CCK-N and PYY mRNA expression in Atlantic salmon. 
With the exception of CCK-N which was not expressed in midgut and hindgut, the genes for 
all peptides were expressed in all GI tract segments analyzed in Atlantic salmon, although at 
different levels. Both CCK-L and CCK-N mRNA expression increased within 1.5 hours past 
feeding (hpf) when the stomach was still ca 80 % full, the gallbladder was nearly empty and 
chyme had started to be transferred into the midgut. The CCK isoforms had different spatial 
and temporal mRNA expression patterns during the 24 h processing of the meal. PYY mRNA 
expression increased at 1.5 hpf and then decreased after 3 hpf. No differences were detected 
between GRLN isoforms and both forms increased after processing of a single meal, 
indicating minor effect of GRLN on regulation of digestion. Taken together this suggests that 
CCK and PYY have in part similar roles in regulating digestive processes to that observed in 
higher vertebrates. The two isoforms of CCK appear to have different functions. The results 
did not identify a role for GRLN in regulating digestion and appetite comparable to mammals. 
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1. Introduction 
1.1 Background 
Atlantic salmon (Salmo salar) is an important species in aquaculture worldwide. The 
global production of Atlantic salmon was estimated to 1 433 708 tons in 2007 and is expected 
to increase in the future (FAO 2007). It is thus of uttermost interest to fish farmers to optimize 
fish growth while at the same time maintaining aquaculture as a sustainable industry. 
Increased knowledge of factors underlying growth, digestion, digestion efficiency, control 
systems of digestion and the integrated aspect of appetite and energy homeostasis is needed to 
ensure continued production of high quality feed for farmed Atlantic salmon when there is a 
gradual reduction of available fish meal and alternative feed ingredients are becoming 
increasingly important.  
1.2 Digestion and absorption 
The main function of the digestive process is to hydrolyze macro nutrients from feed 
in such a way that it can be easily absorbed by enterocytes in the gut and used in catabolic and 
anabolic reactions in the body. The process of digestion is complex and finely orchestrated by 
hormones and neurons culminating in responses such as secretion, motility, absorption and 
evacuation. Factors affecting and modifying digestion includes feed composition, changes in 
habitat characteristics, fish demand of nutrients, and the interplay with additional functions of 
the organism (Krogdahl 2001). The gastrointestinal (GI) tract of fish is a multifunctional 
organ involved not only in digestion, but also in regulation of water and electrolyte balance, 
immunity and endocrine regulation of digestion and metabolism (Buddington et al. 1997). An 
optimal digestive function requires proper coordination between GI tract and associated 
organs such as liver, gallbladder and pancreas.   
Food processing can be divided into three phases; a cephalic phase, a gastric phase and 
an intestinal phase (Silverthorn 2004). The cephalic phase is provoked by the thought, sight, 
smell, taste and chewing of food (Feldman and Richardson 1986). The central nervous system 
(CNS) and enteric nervous system (ENS) are both involved in the cephalic phase. Responses 
elicited are stimulation of secretion and motility in GI tract and accessory organs. The gastric 
phase involves feed entering the stomach. The stomach digests and stores feed, and regulate 
the transit of feed into intestine. During the gastric phase several enzymes, paracrines and 
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hormones are secreted in addition to hydrochloric acid (HCl), mucus and tissue protective 
bicarbonate. Digestion is carried out by both mechanical and chemical breakdown of feed 
creating chyme. The presence of feed in the stomach creates distension of stomach walls 
which activates neuronal and hormonal pathways involved in controlling gastric motility and 
evacuation. Finally, the intestinal phase of digestion involves digestion of chyme entering the 
small intestine. In the intestine these is additional secretions both from pancreas, and the 
gallbladder but also by cells in the GI tract.  
The cephalic phase overlaps and interacts with the gastric and intestinal phase 
contributing to overall GI response to a meal (Katschinski 2000). A wide range of mediators 
are involved in initiating the different phases and responses such as regulating secretion, 
gastric evacuation and gut transit time. The ultimate step of digestion is absorption of 
nutrients and evacuation of undigested material, thus enabling maintenance of body functions 
and growth. The dynamic process of digestion consequently involves multiple steps tightly 
regulated by both hormones and the nervous system. It is thus important to gain increased 
knowledge of the dynamics of meal digestion in relation to GI tract peptide hormones. This 
knowledge may then be useful in understanding the effects of alternative feed sources on 
digestion and growth.    
Feed composition has been shown to influence the efficiency of the different phases of 
digestion. As Atlantic salmon is a carnivorous fish species, the structure and function of the 
digestive system is optimized for processing dietary proteins while it has reduced capacity to 
digest carbohydrates (Hemre et al. 1995; Buddington et al. 1997). The feed composition may 
not only affect the digestive process itself and digestibility, but also the level of feed intake, 
and control of appetite.        
1.3 Challenges of new feed ingredients                                                                              
Animal-based protein sources used in production of fish feeds constitutes a major cost 
of fish farming and is also becoming increasingly scarce as a feed resource (Naylor et al. 
2009). This has led to an increase in use of vegetable ingredients in feed as a substitute for 
fish meal. These plant based proteins sources have been shown to contain variable amounts of 
a range of bioactive compounds many of which cause problems to fish. Feeding soybean meal 
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to salmonids causes enteritis
1
 in the distal intestine, characterized by shortening of mucosal 
folds, widening of lamina propria and infiltration of inflammatory cells (Baeverfjord and 
Krogdahl 1996). In addition to enteritis, reduced activity of digestive enzymes have been 
found in salmonids fed only minor replacements with soybean (Krogdahl et al. 2003). A 
reduced nutrient uptake by the gut caused by decreased carrier-mediated transport of amino 
acids has also been found as a consequence of feeding a diet with 30 % of fish meal protein 
replaced with soybean meal (Nordrum et al. 2000). This poorer utilization of vegetable 
protein has been shown to affect the immune system and ultimately growth in rainbow trout 
(Oncorhynchus mykiss) (Rumsey et al. 1994).  
Reduction in protein utilization and digestion in fish may be caused by the presence of 
antinutritional factors in vegetable derived feed ingredients such as protease inhibitors, 
tannins and lectins (Francis et al. 2001). Studies in Atlantic salmon show that high levels of 
trypsin inhibitors derived from soybean reduce trypsin activity and digestibility of protein and 
fat, and ultimately weight gain (Olli et al. 1994). At low levels of trypsin inhibitor, pyloric 
cecae compensated for trypsin inhibition by producing elevated levels of trypsin (Olli et al. 
1994). In addition to plant derived proteins, carbohydrates are also used in different ratios in 
fish feed. Carbohydrates are cheap feed ingredients which are used for their pellet-binding 
properties and as energy sources (Krogdahl et al. 2005). As a consequence excess amount of 
carbohydrates may be added to the feed, thus above the levels which efficiently can be 
utilized (Krogdahl et al. 2005).  
Studies in Atlantic salmon explain reduction in growth partially by a reduction in feed 
intake when 80-95 % of fish meal is replaced with vegetable protein from wheat, gluten and 
extracted soybean meal (Espe et al. 2006; Torstensen et al. 2008). Plant based ingredients may 
thus inhibit fish growth when added to feed by reducing appetite of fish. It may also be 
possible that the effect of enteritis and enzyme inhibitors partly is mediated through GI tract 
peptide hormones involved in appetite regulation. Studies in farmed rainbow trout  and 
farmed turbot (Scophthalmus maximus) show an increased number of cholecystokinin(CCK)-
8 immunoreactive (IR) cells in fish possibly caused by enteritis due to parasite infection (Bosi 
et al. 2005; Bermúdez et al. 2007). GI tract peptide hormones are key signals linking the 
regulation of digestion to changes in appetite. A reduction in appetite may thus serve as a 
                                                          
1
 Enteritis is characterized as  inflammation of the intestine (Baeverfjord and Krogdahl 1996) 
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protective mechanism in response to negative effects of vegetable feed ingredients or 
parasites. 
In contrast to protein and carbohydrates, the effect of substituting fish oil with 
vegetable oil in fish feed appear to have a somewhat less detrimental effect on fish growth in 
terms of weight and feed conversion ratio, however certain types of lipids may affect muscle 
composition (Bell et al. 2001; Torstensen et al. 2008; Bahuaud et al. 2009). Whether different 
sources of lipids in fish feed result in different responses in appetite, remains to be elucidated.   
Little is known regarding the basic regulation of digestion and absorption of nutrients 
in Atlantic salmon. Knowledge of the regulation of digestion and absorption will aid in 
understanding the physiological and nutritional effects of new feed ingredients and aid in 
optimizing feed composition and feeding regimes in aquaculture. As the digestive process is 
associated with appetite, the regulation of these processes in response to meal processing 
should be studied in Atlantic salmon. GI tract peptide hormones have been shown to be 
mediators of this regulation in mammals and fish (Buddington and Krogdahl 2004; Chaudhri 
et al. 2006).   
1.4 Hormonal regulation of digestion  
The GI tract is the largest endocrine organ in the body and while the endocrine 
regulation of digestion has been extensively studied in mammals, there are only a few studies 
describing these endocrine control systems in fish (see reviews by; (Holst et al. 1996; 
Buddington and Krogdahl 2004)). It has been suggested that the evolutionary signaling 
pathways and molecules involved are conserved among vertebrates, but some available data 
suggest that there are specific differences in fish (Buddington and Krogdahl 2004). These 
authors classify endocrine signaling as three operational networks based on distance of 
communication; including local paracrine, intra-GI tract and intra organ signaling networks. 
The digestive process involves the GI tract and accessory organs which collectively combine 
all of these signaling networks. An example of intra-GI tract signaling is the role of 
Cholecystokinin (CCK) in digestion. When hydrolyzed feed stuff enters the proximal intestine 
in mammals, CCK producing “I” cells in the intestine is stimulated and secretes CCK into the 
circulation (Liddle 1997). CCK then binds to receptors on the gallbladder and pancreas to 
induce secretion of bile and pancreatic enzymes respectively (Liddle 1997).  
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There are various types of GI tract signaling molecules, including hormones, 
neurotransmitters and neuromodulators. Most of the signaling molecules are peptides. Many 
of the regulatory peptide hormones in the GI tract are also involved in the regulation of feed 
intake and appetite control. The close interaction between endocrine and nervous regulation of 
GI tract is confounded by the sharing of similar signaling molecules. Gut hormones influence 
the rate at which feed is transferred to the different compartments of the GI tract, and also the 
level of appetite. Thus, the gut hormones play a dual role in regulation of digestion and 
nutrient uptake, both by optimizing the gut itself for nutrient processing, and by controlling 
the intake of nutrients. Both CNS classical neural reflexes and ENS short reflexes regulate GI 
function (Clements and Raubenheimer 2006). Motility and secretion can thus be altered by 
both hormones and the nervous system. The effect observed include variations in gastric 
emptying, gall bladder contraction and absorption.  
The gut-brain axis provides a higher level of optimizing digestion and absorption, 
where gut hormones can alter food intake by providing a signal from the gut to brain centers 
involved in regulation of feed intake (Chaudhri et al. 2006). The appetite regulating hormones 
described in fish have been reviewed by several authors (Lin et al. 2000b; Volkoff et al. 2005; 
Volkoff 2006). The GI tract peptide hormones Ghrelin, CCK and neuropeptide Y (NPY) 
family of peptides have all been shown to be involved in the regulation of appetite as these 
peptides undergo periprandial variation in mRNA expression and plasma levels (Peyon et al. 
1999; Narnaware and Peter 2001; Unniappan et al. 2004). Ghrelin (GRLN), CCK and PYY 
may thus regulate both the digestive process and appetite in Atlantic salmon.    
1.4.1 GRLN 
GRLN is an acylated peptide initially discovered in rat stomach as an endogenous 
ligand for the growth hormone secretagogue receptor (GHS-R) (Kojima et al. 1999). The 
name is derived from “ghre” meaning “grow” in Proto-Indo-European languages (Kojima et 
al. 1999). Although GRLN was initially shown to regulate growth hormone release from the 
pituitary, later studies showed that GRLN is a multifunctional peptide hormone involved in 
energy homeostasis in mammals (Tschop et al. 2000; Wren et al. 2000; Nakazato et al. 2001). 
GRLNs ranging from 12- to 23- amino acids have been identified in goldfish (Carassius 
auratus) (Unniappan et al. 2002), rainbow trout (Kaiya et al. 2003a), Japanese eel (Anguilla 
japonica) (Kaiya et al. 2003b), Mozambique tilapia (Oreochromis mossambicus) (Kaiya et al. 
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2003c), Nile tilapia (Oreochromis niloticus) (Parhar et al. 2003), channel catfish (Ictalurus 
punctatus) (Kaiya et al. 2005), seabream (Acanthopagrus schlegeli) (Yeung et al. 2006), 
European seabass (Dicentrarchus labrax) (Terova et al. 2008), zebrafish (Danio rerio) 
(Amole and Unniappan 2009) and Atlantic salmon (Murashita et al. 2009). While extensive 
studies in humans and other mammals have described multiple roles of GRLN, the role of 
GRLN in fish is less certain (Unniappan et al. 2004; Jönsson et al. 2007).  
In rats and humans, the mature 28-amino acid GRLN peptide is produced by cleavage 
of a 117 amino acid precursor (Kojima et al. 1999; Kojima et al. 2001). In fish, species to 
species variation exists in the length of the precursor protein, but all teleosts have an amide 
structure on the C-terminus of the mature peptide, (reviewed by; (Kaiya et al. 2008)). A 
unique feature of GRLN is its post translational modification in which Ser-3 is covalently 
linked to octanoic acid. This acyl modification is required for binding to its receptor, GHS-
R1a (Kojima et al. 1999) and thus for exhibiting hormonal effects. GRLN lacking acyl 
modification; des-acyl GRLN, has been identified in rats (Hosoda et al. 2000) and goldfish 
(Matsuda et al. 2006a).  In goldfish des-acyl GRLN can inhibit GRLN-induced food intake 
(Matsuda et al. 2006a). GRLN modified by decanoic acid is the major form in Mozambique 
tilapia (Kaiya et al. 2003c). The “active core” of the peptide in mammals consists of the first 
four N-terminal amino acids including the acyl modification (Bednarek et al. 2000). This is 
required for GHS-R1a binding. Comparison between the N-terminal seven amino acids 
display high sequence homology among non-mammalian vertebrates such as; reptiles, 
amphibians, birds and teleost species (Kaiya et al. 2008).  
In the non-mammalian vertebrates mentioned above the principal site of GRLN 
production was stomach and GI tract, but with species specific differences in tissue 
distribution (Kaiya et al. 2008). Recently Murashita et al. (2009) cloned two GRLN isoforms
2
, 
GRLN-1 (Gene bank acc. no AB443431) and GRLN-2 (Gene bank acc. no AB443432) in 
Atlantic salmon. Both isoforms exhibit highest expression in stomach tissue, with decreasing 
expression levels in pyloric cecae and midgut, adipose tissue and testis. In addition to GI tract, 
GRLN mRNA is expressed in CNS in the hypothalamic arcuate nucleus and in pituitary of 
rats and human, though in lesser extent than the GI tract (Korbonits et al. 2001; Lu et al. 2002; 
                                                          
2
 Murashita et al. (2009) suggest that GRLN-1 and GRLN-2 are alternatively spliced variants of the same gene. 
However, it is uncertain whether CCK-L and CCK-N are separate genes or alternatively spliced mRNA. Even 
though, the term isoforms will be used for both CCKs and GRLNs in this thesis.  
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Mondal et al. 2005). RT-PCR have also detected GRLN mRNA expression in fish brain for 
goldfish (Unniappan et al. 2002), rainbow trout (Kaiya et al. 2003a), Mozambique tilapia 
(Kaiya et al. 2003c), Japanese eel (Kaiya et al. 2003b) and hammerhead shark (Kawakoshi et 
al. 2007).  
In mammals, the gastric fundus is the principal site of GRLN synthesis (Kojima et al. 
1999; Ariyasu et al. 2001; Kojima et al. 2001; Taniaka-Shintani and Watanabe 2005), but 
GRLN can also be found in various other GI tract tissues (Gnanapavan et al. 2002). GRLN is 
produced from X/A like enteroendocrine cells in mucosal epithelium of the stomach, which 
recently have been renamed into “ghrelin cells” (Date et al. 2000; Cummings 2006). GRLN 
has been shown to promote gastric and gut motility in mammals (Peeters 2005). GRLN is 
further secreted into the bloodstream and circulates in the body (Kojima et al. 2001). 
Immunological studies in rats and human found GRLN IR cells in duodenum with a gradual 
decrease in distal intestines from ileum to colon (Date et al. 2000). For a schematic 
presentation of GRLN and its main known effects in mammals, see Figure 1.1. 
GRLN is the endogenous ligand of GHS-R1a receptor and stimulates GH release 
(Kojima et al. 1999). Studies show that GRLN acts directly on the pituitary gland to induce 
GH release in a specific, dose dependent manner in both human and rats (Arvat et al. 2000; 
Seoane et al. 2000; Takaya et al. 2000). GRLN also stimulates GH release in several fish 
species. In vitro studies on Mozambique tilapia organ cultured pituitary cells show that GRLN 
stimulates release of both GH and prolactin in this species (Kaiya et al. 2003c). Though later 
studies failed to reproduce the effect of GRLN induced prolactin release in this species (Fox 
et al. 2007). In addition to studies in tilapia, reports on GRLN induced GH release exist for; 
seabream (Chan and Cheng 2004), goldfish (Unniappan and Peter 2004), orange spotted 
grouper (Epinephelus coioides) (Ran et al. 2004) and rainbow trout (Kaiya et al. 2003a). 
GRLN has also been demonstrated to have a regulatory function on appetite in 
mammals. It is the only orexigenic GI peptide isolated to date, and stimulates food intake in 
mammals (Tschop et al. 2000; Wren et al. 2000; Nakazato et al. 2001). Whether the appetite 
regulatory mechanism is the same for non-mammals is uncertain. Both ICV and IP injection 
of GRLN in goldfish, stimulate food intake (Unniappan et al. 2002; Matsuda et al. 2006a). 
The effect of GRLN has been studied in rainbow trout by measuring periprandial changes in 
GRLN plasma levels and IP injection of GRLN (Jönsson et al. 2007). The result of this study 
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showed no postprandial changes in plasma GRLN levels and no effect on appetite, thus 
concluding no effect of GRLN on appetite regulation in this species. These opposing results 
suggest a species difference in GRLN function. GRLN may have additional roles in fish 
including reproduction, GI motility, water intake, immune function and behavior (Mustonen 
et al. 2002; Kozaka et al. 2003; Matsuda et al. 2006b; Yada et al. 2006; Olsson et al. 2008). 
The role of GRLN in Atlantic salmon is uncertain as very limited information exists for this 
species. The changes of GRLN in response to a meal should thus be studied in order to 
increase the understanding of the regulation of appetite and digestion, and thus verify whether 
GRLN has a potential orexigenic role in Atlantic salmon, similar to mammals. 
1.4.2 CCK 
Cholecystokinin (CCK) was originally identified by Ivy and Oldberg (1928). The 
name refers to “that which excite or moves the gallbladder which was consistent with the 
reported ability to induce gallbladder contraction (Ivy and Oldberg 1928). Since then 
numerous studies in mammals have demonstrated additional CCK regulating effects on 
digestion like stimulation of pancreatic enzyme secretion, inhibition of gastric acid 
production, regulation of gastric emptying (delaying), gut motility (peristalsis) and control of 
appetite (satiety) (Figure 1.1) (Liddle 1997).  
In mammals CCK is secreted by enteroendocrine “I” cells located in the mucosa of the 
proximal intestine, and in neurons in the myenteric plexuses and brain (Chandra and Liddle 
2007). CCK secreting cells have also been identified in proximal GI tract of herring 
(Kamisaka et al. 2005). The I cells have a triangular shape with their apical surface facing the 
intestinal lumen, and the secretory granules with CCK located towards the basolateral base 
(Buchan et al. 1978). CCK is secreted into the blood in response to a meal and binds to CCK-
1 or CCK-2 receptors on target organs, where cellular signal transduction pathways are 
initiated (Chandra and Liddle 2007).  
CCK is also well known as a potent satiety signal in mammals (Moran and Kinzig 
2004). CCK has been identified in a number of teleost species; cod (Gadus morhua) (Jonsson 
et al. 1987), goldfish (Himick and Peter 1994), rainbow trout (Jensen et al. 2001), spotted 
green puffer (Tetraodon nigroviridis) and Japanese flounder (Paralichtys olivaceus) 
(Kurokawa et al. 2003), Atlantic herring (Clupea harengus) (Kamisaka et al. 2005) and 
Atlantic salmon (Murashita et al. 2009). In fish as in mammals, CCK has been shown to 
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regulate digestive function, although less knowledge exist on the endocrine effect of CCK on 
controlling feed intake. 
By measuring gallbladder pressure, Aldman and Holmgren (1995) suggested a 
mechanism for CCK in gallbladder contraction in rainbow trout. In this study it was for the 
first time demonstrated that luminal fat and amino acids entering the proximal intestine 
induced gallbladder contraction by stimulating CCK release (Aldman and Holmgren 1995). 
Subsequent infusion of sulphated CCK octapetide mimicked this effect, which lead to the 
hypothesis that fat and amino acids in the proximal intestine stimulate CCK to induce 
gallbladder contraction. In addition to this effect, CCK is also suggested to have a role in the 
delaying of stomach emptying in the same species (Olsson et al. 1999). In Atlantic salmon, 
infusion of porcine CCK induced pancreatic cell secretion of trypsin and chymotrypsin in 
vitro. The same CCK also induced gallbladder discharge in a dose dependent manner in vivo 
(Einarsson et al. 1997).  
In goldfish, CCK immunoreactivity was found in gut and brain and both centrally and 
peripheral injection of sulfated CCK-8 suppressed food intake (Himick and Peter 1994). High 
levels of CCK IR neurons and mRNA were found in the hypothalamic inferior lobe and 
posterior ventrolateral regions, suggesting that CCK also have a role as a neuroendocrine (and 
neurotransmitter) satiety signal in fish (Himick and Peter 1994; Peyon et al. 1998; Peyon et al. 
1999). Peyon et al. (1999) further demonstrated that CCK mRNA increased 2 hours after a 
meal (postprandial) in goldfish brain. The mechanism CCK induces satiety in fish may be 
both direct by CCK acting as a neurotransmitter in the brain, or indirect through the gut by 
CCK delaying gastric emptying and thus maintaining stomach distension which further 
activates vagal afferents and induces satiety, as seen in rainbow trout (Olsson et al. 1999). In 
both ways vagal pathways are involved, though there might exist non-vagal pathways of 
hormonal relay systems (Bail and Ruf 1997). One such “relay system” may involve leptin, 
which in goldfish potentiates the satiety actions of CCK in hypothalamus and further blocking 
of CCK receptors in the brain attenuates leptin mediated inhibition of NPY and orexin 
(Volkoff et al. 2003b).  
Studies on rainbow trout demonstrated for the first time the identification of three 
different CCK cDNAs in the same species, with the mRNA encoding three CCK 
preprohormones (Jensen et al. 2001). CCK-8 is well conserved in vertebrates within the 
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amino acid sequence; DYMGWMDF (∙NH2) with methionine as the sixth amino acid from 
the carboxy terminal. Amidation of the carboxy terminal is implicated in receptor binding and 
thus biological activity (Johnsen 1998). The three different CCK preprohormones identified in 
rainbow trout, is suggested based on processing signals to give rise to CCK-N (Aspargine), 
CCK-L (Leucine) and CCK-T (Threonine) named according to amino acid variations in C-
terminal position six (Methionine) (Jensen et al. 2001). The three different CCK mRNA 
showed differences in tissue distribution. All CCK forms were expressed in brain and 
intestine. CCK-N showed highest expression in brain and pyloric cecae, while CCK-L was 
expressed more evenly throughout the gut including stomach, small intestine and large 
intestine, altogether potentially suggesting differences in biological functions.  
Recently, Murashita et al (2009) cloned two isoforms of CCK in Atlantic salmon 
based on rainbow trout CCK sequences; CCK-L (GenBank acc.# AB443433) and CCK-N 
(GenBank acc.# AB443434) encoding the precursor peptides prepro-CCK-L and prepro-
CCK-N, respectively (Murashita et al. 2009). When compared within a phylogenetic tree, 
salmonids CCKs separate as CCK-1 and CCK-2, with rainbow trout/Atlantic salmon CCK-N 
and rainbow trout CCK-T falling into CCK-1 group, and rainbow trout/Atlantic salmon CCK-
L in fish CCK-2 group (Murashita et al. 2009). Both CCK-L and CCK-N were mainly 
expressed in Atlantic salmon brain tissue with lower expression in eye (with CCK-L 
expressing the highest level), pyloric cecae and midgut among others (Murashita et al. 2009)  
Recent research has shown an additional role for CCK in mediating a protective effect 
against inflammatory responses in rats fed a high-fat diet (Luyer et al. 2005). Whether this 
effect is the same in fish remains to be elucidated. It is thus important to study the effect of 
CCK in regulating the digestive process and appetite in Atlantic salmon, and also the potential 
involvement in GI tract inflammatory responses. This knowledge may further be useful in 
understanding the growth inhibitory effect of increased inclusions of vegetable derived 
nutrients in fish feed.   
1.4.3 PYY 
PYY is a GI peptide hormone originally discovered in porcine intestine (Tatemoto and 
Mutt 1980). In mammals PYY is synthesized and secreted from intestinal “L” cells located in 
the distal intestinal mucosa, with the apical membrane facing towards the lumen sensing its 
content (Ueno et al. 2008) similar to the CCK “I” cells. In humans PYY release is particularly 
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high when a high-protein meal is ingested (Batterham et al. 2006). PYY immunoreactivity has 
also been located in neuronal cells in the stomach and proximal intestine (Bottcher et al. 
1993). In response to luminal lipids, PYY mediates inhibition of intestinal motility partly by 
the “ileal brake mechanism” where lipids in the distal intestine inhibit motor activity in the 
proximal intestine (Spiller et al. 1984). PYY further inhibits gastric acid secretion and the 
cephalic phase of gallbladder secretion in mammals (Guo et al. 1987; Hoentjen et al. 2001). In 
mammals PYY also inhibits both pancreatic secretion stimulated by secretin and CCK and 
pancreatic secretion stimulated by the vagus nerve and luminal nutrients (Tatemoto 1982; 
Lluis et al. 1987). Thus, PYY act as an endogenous antagonist to CCK‟s stimulation of 
intestinal activity and gallbladder and pancreatic secretion (Figure 1.1). The role of PYY as a 
vasoconstrictor regulating blood flow to splanchnic vasculature may partly mediate these 
inhibitory effects (Adrian et al. 1986; Ueno et al. 2008). The hormone has been shown to have 
additional regulatory roles in mammals including regulation of feeding behavior and body 
weight (see Ueno et al. (2008) for review). 
PYY belongs to the NPY family of peptides which includes; NPY, PYY, PP and PY 
where most are 36 amino acid long peptides including three proline and two tyrosine residues 
constructing the so-called PP-fold (Larhammar 1996). The NPY peptides mediate their effects 
through Y-receptors (Y1, Y2, Y4; Y5, Y6) which differ in their distribution and affinity for 
PYY (Ueno et al. 2008). The enzyme dipetidyl peptidase IV cleaves the N-terminal tyrosine 
and proline residues generating Y2 receptor specific PYY3-36 which is the major form in 
circulation as well as gut endocrine cells (Mentlein et al. 1993; Grandt et al. 1994). Y2 
receptors can be found in the hypothalamus (including ARC), intestine and on vagal afferent 
nerves in mammals (Koda et al. 2005). In mammals, the role of PYY as a satiety factor is 
believed to be mediated through Y2 receptors on vagal afferents signaling to hypothalamic 
ARC via NTS in the brainstem (Ueno et al. 2008).  
In fish, PYY sequences have been detected in lamprey (Soderberg et al. 1994), 
zebrafish (Larhammar et al. 1995), seabass (Cerda-Reverter et al. 2000), Japanese flounder 
(Kurokawa and Suzuki 2002), pufferfish, three-spined stickleback, medaka and torafagu 
(Sundstrom et al. 2008). Much of the research on PYY in fish has focused on the evolution of 
the neuropeptide Y family of peptides (Larhammar 1996; Sundstrom et al. 2008). Studies 
indicate that NPY and PYY evolved from a gene duplication event from a common ancestral 
gene, and a second duplication of PYY gave rise to PY (renamed PYYb) (Sundstrom et al. 
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2008). There appear to be a difference in distribution of PYY in fish compared to mammals, 
with fish PYY being more widespread in the nervous system and endocrine cells (Cerda-
Reverter and Larhammar 2000; Soderberg et al. 2000; Kurokawa and Suzuki 2002). Recently 
Murashita et al. (2009) cloned the PYY gene in Atlantic salmon. Atlantic salmon PYY were 
found to be highly expressed in midgut, pyloric cecae and brain, with lower expression in 
eyes, stomach, adipose tissue and gonads (Murashita et al. 2009). In fish, PYY may thus be 
expressed in more proximal parts of the digestive system in contrast to mammals. The role of 
PYY in fish is unknown.   
 
 
 
Figure 1.1. Central and peripheral effects of key gastrointestinal (GI) tract peptide hormones in 
mammals. See next page for legend (page 19). 
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Figure 1.1. Central and peripheral effects of key gastrointestinal (GI) tract peptide hormones in 
mammals. The figure shows a schematic overview of the brain and GI tract compartments covering; 
stomach, pyloric region, midgut and hindgut. The area between the stomach and pyloric region 
illustrates the pyloric sphincter, while the pyloric region includes the proximal intestine. The origin of 
the lines indicates known site of peptide hormone secreting cells, while the end of the line indicates a 
stimulatory or an inhibitory effect on the target. A line originating and ending from/at the same target 
indicates a local, paracrine effect. The effect of Ghrelin (GRLN), cholecystokinin (CCK) and peptide-
YY (PYY) are thought to be mediated both through the circulation and by activation of the nervous 
system, where they ultimately bind to receptors on their target. The dotted line illustrates GI tract 
peptide hormones mediating a signal from GI tract to brain areas. The central effects of each peptide 
hormone are listed below each peptide hormone on the top of the figure, while the peripheral effect is 
listed on the bottom of the figure. Arrows pointing upwards next to a described effect indicate a 
stimulatory effect, while arrows pointing downwards indicate inhibitory effect. GH: Growth hormone, 
HCl: Hydrochloric acid, Secr: Secretion. The scheme is compiled from available literature (see text 
for details)     
1.5 Summary 
In summary, studies in fish indicate that GRLN, CCK and PYY are involved in the 
optimization of the digestive process and may also affect appetite (Figure 1.1). The dynamic 
process of digestion includes several phases initiated by higher levels in brain areas and the 
presence of feed in the GI tract, and the integrated response between digestion and appetite. 
The GI tract peptide hormones provide a finely tuned network of signaling molecules which 
mediates information from the gut and brain. The effects initiated by GI tract hormones in 
mammals involve regulation of gastric evacuation, gut transit of chyme, gallbladder 
contraction, pancreatic secretion and appetite (feed intake) (Figure 1.1).  
In fish, less is known about the regulatory role of GI tract hormones. The large 
differences in environmental conditions and feed sources between mammals and fish could 
potentially result in a different response to luminal factors, hence alternative modes of 
digestive regulation. As fish constitutes a highly diverse group of species, species specific 
differences in regulation of digestion may exist. Species specific differences may include 
alternative isoforms, differential spatial distribution in the GI tract and different functions of 
the same GI tract peptide hormones. Consequently, when studying the role of GI tract peptide 
hormones in fish, a species specific approach needs to be chosen.  
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GRLN, CCK and PYY were recently cloned and characterized in Atlantic salmon 
(Murashita et al. 2009). However, no information was available on the short term postprandial 
effects on mRNA expression of these peptide hormones in the GI tract. Therefore an 
experiment was initiated with the aim of increasing the knowledge of postprandial regulation 
of the digestive process and appetite by GI tract peptide hormones in Atlantic salmon. Very 
limited information exists concerning changes in GRLN, CCK and PYY in relation to meal 
processing in Atlantic salmon, and studies on these genes in relation to meal digestion have 
only recently been described in goldfish and tilapia (Unniappan et al. 2004; Fox et al. 2009).  
1.6 Hypothesis and aim of thesis 
The hypothesis is that GRLN-1, GRLN-2, PYY, CCK-L and CCK-N are involved in 
the regulation of digestion and appetite in Atlantic salmon similar to mammals. If this is the 
case, these peptide hormones are expected to change in mRNA expression according to the 
dynamic process of digestion and appetite including stomach filling and evacuation, release of 
bile and pancreatic secretion, and the transit of feed through the gut. The regional distribution 
pattern of each peptide hormone is expected to reflect its role in the GI tract. If GRLN-1, 
GRLN-2, PYY, CCK-L and CCK-N are involved in regulation of digestion and appetite, 
potential postprandial changes in gene expression is expected to occur at specific time points 
related to the phase of digestion.  
In order to test this hypothesis an experiment was conducted were Atlantic salmon 
were fed a single meal and the gene expression was analyzed during the postprandial 
processing until the GI tract was empty. Unfed fish were used as control and to determine 
potential diurnal patterns in mRNA expression. The main aim of the experiment was to:   
1) Describe the regional tissue distribution of GRLN-1, GRLN-2, PYY, CCK-L and 
CCK-N mRNA in stomach, pyloric cecae, midgut and hindgut.  
2) Describe the processing of a single meal by looking at; changes in stomach filling and 
emptying, gut transit assessed as filling of pyloric cecae, midgut and hindgut.  
3) Describe the release of bile and subsequent refilling of the gallbladder during 
processing of a meal. 
4) Describe the regulation of meal digestion by analyzing postprandial changes in mRNA 
expression of GRLN-1, GRLN-2, PYY, CCK-L and CCK-N during complete 
digestion of a meal. 
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5) Describe the potential involvement of GRLN-1, GRLN-2, PYY, CCK-L and CCK-N 
in regulation of appetite by analyzing postprandial changes in mRNA expression 
during complete digestion of a meal. 
6) Describe the diurnal variation in GRLN-1, GRLN-2, PYY, CCK-L and CCK-N by 
analyzing mRNA expression of these peptide hormones in unfed Atlantic salmon. 
 
In this thesis GRLN, CCK and NPY are discussed as peptide hormones and thus refer 
to a group of peptides with described roles of hormones. GRLN, CCK and PYY have all been 
shown to act both in an endocrine and in a local paracrine manner. We therefore emphasize 
that we are not excluding additional modes of action. 
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2. Material and methods 
2.1 Animals and samples 
Atlantic salmon average body weight 44.7 ± 2.1 g, were reared at the Bergen High-
Technology centre in indoor tanks supplied with a continuous flow of fresh water at 8° C and 
with a light regime of 12:12. The fish were fed a commercial pellet diet (EWOS, Bergen, 
Norway); see Appendix IV (Table AIV1). Two weeks prior to the postprandial sampling fish 
were divided in to two tanks, and hand fed ad libitum at 0900 every morning (7 days/week). 
At the first day of sampling, 6 fish in the first tank (unfed group) were sampled at each 
selected time point (0, 0.5, 1.5, 3, 6, 9, 12 and 24 hours), whereas fish in the second tank 
received food (fed group) as usual. Before sampling the second day, fish were fed as 
described above.   
At sampling fish were anaesthetized using 50 mg/l MS-222 and killed with a blow to the 
head. The weight and length of each fish was recorded before the whole GI tract was 
removed. All dissecting work was done using dry-ice. The GI tract was selected for q-PCR, 
and the whole gallbladder and GI tract content were selected for weight assessment. The GI 
tract was divided into four segments as indicated in Figure 2.1, consisting of stomach, pyloric 
cecae, midgut and hindgut. The intestine was emptied of any leftover food and chyme by 
gently striking the content out in to pre-weighed aluminium foils. The stomach, midgut and 
hindgut segments were then each divided into three segments. Segments were then 
flashfrozen using liquid nitrogen, and stored at –80 ºC until further use. The gall bladder was 
collected in pre-weighed eppendorf tubes.   
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Figure 2.1. The Atlantic salmon gastrointestinal (GI) tract. The picture shows an unfolded GI tract 
representative for Atlantic salmon sampled in this experiment (average weight 44.7 ± 2.1 g). During 
sampling, the GI tract  were first cut into four main segments consisting of stomach, pyloric cecae 
region, midgut and hindgut segments indicated by the dotted line and the area between. The triangles 
below the end of each dotted line indicate cutting points. Food and chyme were emptied from stomach, 
pyloric cecae intestinal region, midgut and hindgut segments. Each segment excluding pyloric cecae 
region were then cut into three segments indicated by the arrows. Pyloric cecae used in gene 
expression analyses were cut at the indicated arrow at the base of the shaded area. In the current 
study S2, S4, S6 and S9 (indicated by the shaded areas and blue letters) were analyzed by q-PCR as 
these are representative for their respective GI regions. The gallbladder was cut off from the intestine 
and weighed with content (cutting point indicated by an arrow).      
2.2 RNA isolation 
Total RNA was isolated according to (Chomczynski 1993) from Atlantic salmon GI tract 
segments including; stomach (S2), pyloric cecae (S4), midgut (S6) and hindgut (S9), using 
TRI Reagent® (Sigma, USA) for phenol-chloroform extraction.  
Tissue samples were brought directly from -80 °C freezer and cut on dry ice to avoid thawing, 
then weighed. Each sample was kept in the weight range of 40-45 mg ± 10%. The tissue 
samples were quickly transferred to 2 ml FastPrep homogenization vials for tissue disruption, 
each vial containing 1 mL cold TRI Reagent® and kept on ice for at least 5 min. Tissue 
homogenization was executed using FastPrep™ FP120, BIO101 ThermoSavant (Q-BIOgene, 
USA), with the following settings: speed 4 for 20 seconds. The samples were then kept at 
room temperature (RT), for 5 minutes. Two hundred µl Chlorofrom (Sigma, USA) was added 
and samples thoroughly vortexed for 1 minute until appearance of a milky-white color. To 
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achieve phase separation, the samples were centrifuged for 15 minutes, 12000 x g on 4 °C 
(Eppendorf Centrifuge, 5415R, Heracus Instruments, Germany). The upper phase clear 
supernatant (approximately 360 µl), was transferred to a clean 1.5 mL microcentrifuge tube 
(Axygen, USA) leaving a small volume left to avoid DNA and protein residues. Five hundred 
µl of Isopropanol (Sigma) was added to the supernatant, sample inverted five times for 
mixing then left for precipitation of RNA for 10 minutes at RT. RNA was precipitated by 
centrifugation for 15 minutes, 12000 x g and 4 °C. To ensure a sample with pure RNA, the 
pellet was washed with 500 ul 80 % Ethanol (Arcus, Norway). The samples were centrifuged 
for 5 minutes, 7600 x g on 4 °C and the supernatant wash removed. Since ethanol may disturb 
further enzymatic analysis, all traces of ethanol were removed thoroughly. The samples were 
subsequently air dried for 5-10 minutes and reconstituted in 100 µl Nuclease-Free Water 
(Ambion, USA). Samples were placed on a heating block (Techne DRI-BLOCK, DB-3D, 
Techne, USA) for 5 min at 55 °C, with casual flicking of the vials to ensure a completely 
dissolved pellet.  
2.3 RNA concentration and quality 
RNA concentration was measured using NanoDrop ND-1000 absorbance technology (Thermo 
Scientific, USA), where 1.5 µl of total RNA was added to NanoDrop ND-1000 and 
quantitative/qualitative measurements were recorded. The 260/280 and 260/230 absorbance 
ratio were used as indicators of sample quality in terms of sample pureness. Concentration 
measurements for all samples were used as basis for calculations in downstream enzymatic 
reactions.  
2.4 RNA integrity 
RNA integrity was tested by the use of a RIN algorithm („RNA Integrity Number‟ (RIN)) on 
the Agilent 2100 Bioanalyzer (Agilent Technologies, USA) in conjunction with RNA 6000 
Nano and RNA 6000 Pico LabChip kit (Agilent Technologies) to test sample RNA integrity. 
The procedure was followed according to manufacturer‟s guidelines.  
2.5 DNase treatment of RNA 
To remove traces of genomic DNA, TURBO DNA-free Kit™ (Ambion) was used on total 
isolated RNA, following manufacturer‟s instructions for Routine DNase treatment, with one 
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modification: instead of using 10 µg of total RNA into reaction, 12 µg was used. One sample 
was split into two parallels in DNase treatment. To minimize loss of RNA during precipitation 
and storage these samples were pooled and co-precipitated
3
.  
2.6 cDNA synthesis 
cDNA was synthesized using Superscript III First-Strand Synthesis System (Invitrogen, USA) 
on 5 µg total RNA template. Oligo(dT) (Sigma, USA) was chosen as primer as it maximizes 
the number of mRNA molecules available for analysis in a small sample of RNA. Each 
individual sample was split into two parallels and kept as parallels during q-PCR. All reagents 
used were provided with the Superscript III kit. Eight µl of RNA sample and 1 µl of dNTPs 
and 1 µl of oligo(dT) was heat denatured for 5 min at 65 °C in Gene Amp PCR 2700 machine 
(ABI, USA) to limit secondary structures, then chilled on ice for at least 1 min for the primer 
to anneal properly. A mastermix containing RT buffer, MgCl2, DTT, and SuperScript™ III 
RT was made to a total volume of 10 µl and added to the RNA/primer mixture. Samples were 
then heated at 50 °C for 50 min which is the optimum temperature for SuperScript™ III RT, 
85 °C for 5 min for reaction termination, then chilled on ice. To remove RNA in the sample, 
one µl RNase H was added to each tube an incubated for 20 min at 37 °C. The cDNA 
reactions were stored in -20 °C freezer. Two negative controls were made by using RNA 
sample leftovers from all samples during each run, one excluding the SuperScript™ III RT, 
and one excluding the oligo(dT) primer. All reactions were run on Gene Amp PCR 2700 
machine (ABI, USA). 
2.7 Real-time quantitative PCR: quantification of gene expression 
Real-time quantitative PCR (q-PCR) was used to measure mRNA expression in Atlantic 
salmon stomach, pyloric cecae, midgut and hindgut. Q-PCR amplification and analysis were 
performed using Chromo4 Continuous Fluorescence Detector (Bio-Rad) and MJ Opticom 
Monitor Analysis software (Version 3.1, Bio-Rad). For GRLN-1, GRLN-2 and Atlantic 
salmon elongation factor 1α (EF1α) 100 ng cDNA was used. Atlantic salmon EF1α was used 
as an internal standard reference gene. For PYY, CCK-N and CCK-L 500 ng cDNA was used. 
                                                          
3
 All samples were precipitated with 1/10 of total sample volume with 3 M Sodium Acetate 
(pH 5.5) (Ambion) and 2.5 sample volume with 80 % Ethanol, then kept in -80 °C freezer for 
storage. 
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The quantities selected were within the range of the standard curve for the respective gene. 
Total q-PCR reaction volume of 25 µl was prepared using; 2.5 µl diluted cDNA, 12.5 µl 
Power SYBR
®
 Green PCR Master Mix (Applied Biosystems), 0.75 µl forward primer (10 
µM), 0.75 µl reverse primer (10 µM) and 8.5 µl Nuclease-Free Water (Ambion). See Table 
2.1 for Genebank accession number and primer sequences. The enzymatic amplification 
reactions were carried out in 96-Well Skirted PCR plates (Bio-Rad) with thermal cycling 
protocol: A first degeneration at 94 °C for 3 min then 40 cycles at 94 °C for 30 s, 60 °C for 30 
s and 72 °C for 30 s. A melting curve was performed for each assay to verify the absence of 
primer dimers (60-95 °C, read every 0.2 °C and hold for 1 sec).  
Each sample was run in duplicate reactions kept from the cDNA synthesis. Standards were 
also run in duplicates. Controls included in each plate were; non template negative control, a 
between plate control and minus RT. Cycle threshold was set manually to 0.010 which was 
within the exponential phase and above background noise for all assays. Q-PCR data were 
analyzed in RJ Opticom 3.2.32 (Bio-Rad) software and exported to Excel® and Statistica 8.0 
(StatSoft, Inc., USA) for further analysis. 
Table 2.1: Primer sequences used in q-PCR 
Gene Genebank  
Acc. No. 
Primer name Sequence (5’-3’) 
 
GRLN-1 
 
 
AB443431 
 
Ghr Fw3 
Ghr Rv3 
 
CCAGAAACCACAGGTAAGACAGGGTA 
CTCCTGAAACTCCTCCTCACTCATGG 
 
GRLN-2 
 
AB443432 
 
Ghr Fw4 
Ghr Rv3 
 
 
GCCCCTCCCAGAAACCACAGGGTAAA 
CTCCTGAAACTCCTCCTCACTCATGG 
PYY 
 
AB443435 PYY Fw5 
PYY Rv5 
 
ACTACACCGCGCTCAGACACTACATC 
TCTCTGGTCTCTCTCTGCATTGTTGCCG 
CCK-L 
 
AB443433 CCK-L Fw3 
CCK-L Rv3 
 
GCGCGAACTACTGGCAAGATTGATA 
TGTCCTTTATCTTGTGGCTGGGACCCG 
CCK-N 
 
AB443434 CCK-N Fw3 
CCK-N Rv3 
 
CCTCTGAAGCACGTCTTGAAGCCTAC 
GAGATGAGTCTAGCCAACAGTTCACTGA 
EF1α AF321836 Ss EF1 SYBR Fw 
Ss EF1 SYBR Rv 
GAGAACCATTGAGAAGTTCGAGAAG 
GCACCCAGGCATACTTGAAAG 
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2.8 Calculation of copy number 
The resulting cycle threshold (Ct) values from the two parallels of each sample were averaged 
and the average deviation between sample Ct values calculated. Samples with average 
deviation between parallels exceeding 20 % were rerun in q-PCR.  
A dilution series of plasmid recDNA standards prepared was analyzed in duplicate reactions 
by q-PCR for each assay. The plasmid recDNA standards was made by Dr. Koji Murashita, 
(Murashita et al. 2009) according to protocols from Applied Biosystems (AppliedBiosystems 
2003).   
Standard curves were prepared by plotting the Ct values against the logarithm of the copy 
numbers in the standards, and linear regression was performed (Bustin 2000). The initial copy 
number was calculated using the following equation: 
 
Ct = - slope ∙ (Ci) + intercept       (Equation 2.1) 
Where Ct is the sample Ct value from q-PCR and Ci is the unknown initial copy number in 
the sample. Rewriting equation (2.1): 
 
Ci = (Ct – intercept) / (- slope)       (Equation 2.2) 
 
Based on the constructed dilution curves of the standard, the R
2 
was calculated using least 
square linear regression, resulting in values > 0.99 for all assays. The obtained copy numbers 
for all samples were normalized against Atlantic salmon elongation factor 1 α by dividing 
sample copy number on EF1a copy number (target gene/reference gene).  
2.9 Statistical analysis 
All statistical analysis was performed in Statistica 8.0 (StatSoft, Inc., USA). Both unfed and 
fed fish groups were tested for normality within all time groups in separate segments (S2, S4, 
S6 and S9), using Shapiro-Wilk W-test. Homogeneity of variance was tested on the same 
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groups with Levene‟s F-test. Significant differences in mRNA copy number expression was 
determined with main effects ANOVA using fish group (unfed, fed) and time as effects. For 
both unfed and fed fish, a one way ANOVA was included to determine changes caused by 
time alone within each group. In addition an independent between-variable t-test was 
performed to determine differences between unfed and fed fish group means at each time 
point. For differences in mRNA expression between segments within each gene, factorial 
ANOVA was used with fish group and segment as variables.     
The null hypothesis was rejected at significance level α < 0.05, and a Tukey HSD post-hoc 
test was then followed up. Log transformation of data was performed to better meet the 
assumptions of ANOVA for normal distribution and homogeneity of variance. Some groups 
still failed to meet these demands (see Appendix III).  
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3. Results 
3.1 GI tract compartment content and gallbladder weight 
3.1.1 GI tract compartment content 
Four compartments of the GI tract were assessed through the weighing of their 
contents to assess the amount of contents of feed and chyme. The average feed intake was 
estimated to 3.9 % (GI tract content (g) / average fish weight (g) at time 0.5). At the first 
sampling point, 30 min after termination of the meal, most of the ingested food (ca 87 %) was 
still in the stomach with only a small fraction transferred into the pyloric segment (Figure 
3.1.1, a). Subsequently, there was a rapid emptying of stomach content and ca 50 % had been 
transferred from stomach at 4.5 hpf. Most of the stomach content (ca 83%) was emptied at 9-
12 hpf, and at 24 hpf the stomach was empty. The unfed fish had an empty stomach 
throughout the experiment confirmed by visual inspection and content weight (Figure 3.1.1, 
b). The graph presenting measurements of pyloric cecae (S4) contents in fed fish (Figure 
3.1.1, a) displayed a more gradual content increase, lacking a distinct peak but showed a 
decreasing trend from 9 hpf towards 24 hpf where it was empty. The midgut and hindgut 
compartments in fed fish displayed a weak gradual increase in chyme towards 12 h past 
feeding followed by minimal content at 24 hpf. In unfed fish, all gut compartments showed 
minimal and stable chyme content within the time of the experiment (Figure 3.1.1, b). 
3.1.2 Gallbladder content   
The gallbladder showed a rapid release of content 0.5 h past feeding shown by a decrease in 
gallbladder weight (g) (Figure 3.1.2, a). At 1.5 hpf the gallbladder was empty.  From 6 and 9 
hpf bile there was an increase in gallbladder weight (Figure 3.1.2, a). At 24 hpf the 
gallbladder shows high content levels equal to time 0 h (prefeeding levels). There are no 
differences in gallbladder weight throughout the whole sampling period for the unfed fish 
group (Figure 3.1.2, b).  
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Figure 3.1.1 Measurements of GIT compartment content (g). The data in graph (a) are 
represented as the average weight (g) of feed and chyme of each GIT compartment (stomach, pyloric 
cecae, midgut and hindgut) for six fish sampled at time (h): 0 (prefeeding), and 0.5, 1.5, 3, 6, 9, 12 and 
24 after feeding ± SD. In (b) the data are represented as in (a), but for fish fasted for 24 h prior to 
sampling (Time (h): 0) and throughout the sampling period (unfed for 48 h in total). The data point for 
each segment at each time point is shifted relative to each other to better distinguish the segments. The 
fish in (a) and (b) were kept in separate tanks during the experiment. 
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Figure 3.1.2 Measurements of gallbladder weight (g). Graph (a) and (b) each represents the 
average weight of the gallbladder (g) for six fish sampled at time (h): 0 (prefeeding), 0.5, 1.5, 3, 6, 9, 
12 and 24 after feeding in (a) = fed fish (with the exception of time (h): 0 which is fish sampled prior 
to feeding), and 24 h since last meal prior to sampling in (b) = unfed fish. The dotted line represents 
the weight (g) of an empty gallbladder (a gallbladder with minimal content). 
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3.2 Spatial distribution of GRLN-1, GRLN-2, PYY, CCK-L and CCK-N mRNA 
in Atlantic salmon GIT 
3.2.1 GRLN-1 
GRLN-1 mRNA copy numbers was highest in stomach tissue (S2) of Atlantic salmon. Figure 
3.2.1 shows the GRLN-1 average copy numbers at all selected time points for each fish group 
(fed/unfed). GRLN-1 exhibited significantly lower copy numbers in pyloric cecae (S4), 
midgut (S6) and hindgut (S9) tissue (p<0.05) compared to stomach (S2), using factorial 
ANOVA. The hindgut (S9) exhibited lowest GRLN-1 mRNA copy numbers (p<0.01), (Figure 
3.2.1, Segment 9). No significant difference in GRLN-1 mRNA copy numbers were found 
between pyloric cecae (S4) and midgut (S6) tissue for any of the fish. GRLN-1 mRNA copy 
numbers were not significant different between unfed and fed fish for any of the segments.  
3.2.2 GRLN-2 
GRLN-2 average mRNA copy numbers were highest in stomach tissue (S2) (Figure 3.2.2). 
GRLN-2 appeared to have the same spatial mRNA expression pattern as GRLN-1 in Atlantic 
salmon. The factorial ANOVA and post-hoc Tukey HSD test, showed statistical significant 
lower GRLN-2 copy numbers in pyloric cecae (S4), midgut (S6) and hindgut (S9) tissue 
(p<0.05) compared to stomach (S2) (p<0.001). GRLN-2 copy numbers in hindgut (S9) 
showed significant lower copy numbers than all other tissues studied (p<0.001, Tukey HSD).  
No significant difference in mRNA expression of GRLN-2 could be seen between fed and 
unfed fish for any of the tissues.  
3.2.3 PYY 
PYY mRNA copy numbers were higher in pyloric cecae (S4) and midgut (S6) in Atlantic 
salmon compared to stomach (S2) and hindgut (S9) tissue (p<0.001) (Figure 3.2.3). Fed fish 
exhibited higher PYY copy numbers than unfed fish in the stomach (S2) (p<0.05). The 
hindgut (S9) of Atlantic salmon was the third most expressing tissue of PYY mRNA, and 
exhibited a significant higher PYY copy number than stomach tissue (S2) (p<0.001). The 
largest variation in PYY copy numbers within fish groups were found in stomach tissue (S2) 
(unfed fish SD=0.02 and fed fish SD=0.03). The lowest variation within fish groups was 
found in midgut (S6) tissue for unfed and fed fish (SD=0.005 for both groups). No significant 
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differences were found in PYY mRNA copy numbers between pyloric cecae (S4) or midgut 
(S6) tissues for fed and unfed fish. 
3.2.4 CCK-L 
CCK-L mRNA copy numbers were found to be significant higher (p<0.01) in hindgut (S9) 
tissue of Atlantic salmon, compared with those in stomach (S2), pyloric cecae (S4) and 
midgut tissue (S6) (Figure 3.2.4). CCK-L copy numbers were expressed in moderate levels in 
pyloric cecae (S4) and midgut (S6). Stomach (S2) exhibited the lowest level of CCK-L copy 
numbers (p<0.001) compared to the other segments. Pyloric cecae showed the largest 
variation within each fish group compared with the other tissues, indicated by the error bars 
(±SD) in Figure 3.2.4. No significant differences were found in CCK-L mRNA expression 
between unfed and fed fish in any of the segments analyzed. 
3.2.5 CCK-N 
CCK-N mRNA copy numbers were found in stomach (S2) and pyloric cecae (S4) of Atlantic 
salmon (Figure 3.2.5). No significant differences in CCK-N copy numbers were detected 
between stomach (S2) and pyloric cecae (S4), neither between fish groups (fed/unfed) within 
each tissue (S2 and S4). Atlantic salmon only expressed low levels of CCK-N mRNA in 
midgut (S6) and hindgut (S9). Several fish sampled in these compartments were below the 
detectable limit for q-PCR. No statistical analyses could thus be performed on these two 
tissues.  
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Figur 3.2.1. GRLN-1 mRNA distribution in Atlantic salmon GI tract. Data are represented as 
mean calculated copy number for unfed fish (n= 18), and fed fish (n= 15) normalized against Atlantic 
salmon EF1α copy numbers ((copy numbers of target gene/copy numbers of EF1a reference gene) ± 
SD), for GI tract segments; stomach (2), pyloric cecae (4), midgut (6) and hindgut (9). 
 
Figur 3.2.2. GRLN-2 mRNA distribution in Atlantic salmon GI tract. See caption in Figure 3.2.1 
for information on data representation.  
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Figur 3.2.3. PYY mRNA distribution in Atlantic salmon GI tract. See caption in Figure 3.2.1 for 
information on data representation. An asterisk above bars represents significant differences between 
unfed and fed fish within a segment.  
 
Figur 3.2.4. CCK-L mRNA distribution in Atlantic salmon GI tract. See caption in Figure 3.2.1 
for information on data representation. 
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Figur 3.2.5. CCK-N mRNA distribution in Atlantic salmon GI tract. See caption in Figure 3.2.1 
for information on data representation. Several fish in midgut and hindgut tissue (Segment 6 and 9) 
showed CCK-N mRNA expression below the detectable limit for q-PCR. The bars representing midgut 
and hindgut should thus be interpreted with some caution as these bars include only the fish which 
showed CCK-N mRNA levels above the detectable limit in q-PCR. 
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3.3 Postprandial effect on mRNA copy numbers of GRLN-1, GRLN-2, PYY, 
CCK-L and CCK-N in Atlantic salmon GI tract 
3.3.1 GRLN-1 
Significant differences in mRNA copy numbers of GRLN-1 were found between unfed and 
fed fish in midgut (S6) (p<0.05), (Figure 3.3.1; c) and in hindgut (S9) (p<0.05), (Figure 3.3.1; 
d) at time 24 h. No significant differences were found in GRLN-1 mRNA expression between 
fed and unfed fish in stomach (S2), (Figure 3.3.1; a) or pyloric cecae (S4), (Figure 3.3.1; b). 
The mRNA expression pattern of GRLN-1 in stomach (S2) is the same for fed and unfed fish.  
ANOVA analysis of main effects using time (h) and fish groups (fed, unfed) as effects, and 
one-way ANOVA to identify the influence of time within each fish group, did not show 
significant values at p<0.05.  
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Figure 3.3.1. GRLN-1 copy numbers in Atlantic salmon GI tract. GRLN-1 mRNA copy numbers 
are shown for stomach (a), pyloric cecae (b), midgut (c) and hindgut (d). Data are presented as mean 
(n=3) calculated copy number (±S.D) normalized against EF1α reference gene (copy numbers), for 
unfed fish (black square) and fed fish (red triangle) at time (h); 0.5, 1.5, 3, 6 and 24. Time 0 is 
represented for unfed fish only. Mean values with an asterisk above show significant differences 
between fish groups at a given time point (p<0.5). 
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3.3.2 GRLN-2 
Significant higher GRLN-2 copy numbers (p<0.05) were found in fed fish than unfed fish at 
time 24 h in midgut (S6) (Figure 3.3.2; c) and hindgut (S9) (Figure 3.3.2; d) of Atlantic 
salmon. No significant differences were found between fish groups at time; 0.5, 1.5, 3 and 6 
hour (t-test) in any of the gut tissues studied (Figure 3.3.2; a, b, c, d). No significant 
differences were found between fish groups in stomach (S2) tissue (Figure 3.3.2; a) or pyloric 
cecae (Figure 3.3.2; b). GRLN-2 copy numbers in stomach (S2) exhibited the lowest variation 
in copy numbers both between and within fish groups (Figure 3.3.2; a). 
ANOVA analysis of main effects using time (h) and fish groups (fed, unfed) as effects 
showed significant values at p<0.05 for fish group as an effect. No significant differences 
were found in one-way ANOVA using time as an independent factor for each fish group. 
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Figure 3.3.2. GRLN-2 copy numbers in Atlantic salmon GI tract. GRLN-2 mRNA copy numbers 
are shown for stomach (a), pyloric cecae (b), midgut (c) and hindgut (d). See caption in Figure 3.3.1 
for information on data representation. 
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3.3.3 PYY 
Significant differences in PYY mRNA copy numbers were found between unfed and fed fish 
in hindgut (S9) of Atlantic salmon at time 1.5 h, 3 h and 24 h (p<0.05), (Figure 3.3.3; d). In 
hindgut (S9) at time 1.5 h, fed fish exhibited higher PYY copy numbers than unfed fish. At 
time 3 h and 24 h unfed fish exhibited the highest PYY copy numbers in hindgut (S9). No 
significant differences were found in PYY mRNA copy numbers between unfed or fed fish in; 
stomach (S2), pyloric cecae (S4) or midgut (S6) (Figure 3.3.3; a, b and c, respectively). 
Stomach (S2) tissue showed more variation within the time groups than pyloric cecae (S4), 
midgut (S6) and hindgut (S9), indicated by the standard deviation (SD) in Figure 3.3.3; a.  
ANOVA analysis of main effects using time (h) and fish groups (fed, fasted) as effects 
showed significant values at p<0.05 for time on PYY mRNA expression in midgut, the Tukey 
HSD post-hoc test found this significant difference in PYY copy numbers between time 0 h 
and 1.5 h in midgut. However the one-way ANOVA using time as independent factor for each 
fish group did not show any significant effect of time alone. 
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Figure 3.3.3. PYY copy numbers in Atlantic salmon GI tract. PYY mRNA copy numbers are shown 
for stomach (a), pyloric cecae (b), midgut (c) and hindgut (d). See caption in Figure 3.3.1 for 
information on data representation. 
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3.3.4 CCK-L 
Significant differences in CCK-L mRNA copy numbers (p<0.05) were found between fed and 
unfed fish in stomach (S2) of Atlantic salmon at time 3 h, where unfed fish exhibited higher 
CCK-L copy numbers than fed fish (Figure 3.3.4; a). Significant higher CCK-L copy numbers 
were found in the midgut (S6) of fed fish at time 0.5 h and time 24 h (p<0.05), than in unfed 
fish at the same time points (Figure 3.3.4; c). CCK-L copy numbers were significantly higher 
in unfed fish than fed fish at time 1.5 h postprandial (p<0.05) in hindgut (S9) (Figure 3.3.4; 
d). No significant differences between fish groups were found in pyloric cecae (S4) (Figure 
3.3.4; b).  
Results from main effect ANOVA using time (h) and fish groups (unfed, fed) as effects 
showed significant effect of time at p<0.05 on CCK-L copy numbers in pyloric cecae. The 
followed up Tukey HSD post hoc test, found this significant effect between time 0 h and 0.5 h 
(p<0.05). Main effect ANOVA detected additional significant effects of fish group on CCK-L 
mRNA copy numbers in stomach (S2) (p<0.01) and midgut (S6) (p<0.01). No significant 
effect of time was detected using one-way ANOVA with time as independent factor on CCK-
L copy numbers within each fish group (fed/unfed).  
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Figure 3.3.4. CCK-L copy numbers in Atlantic salmon GI tract. CCK-L mRNA copy numbers are 
shown for stomach (a), pyloric cecae (b), midgut (c) and hindgut (d). See caption in Figure 3.3.1 for 
information on data representation. 
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3.3.5 CCK-N  
CCK-N mRNA copy numbers in Atlantic salmon stomach (S2) exhibited significant 
differences (p<0.05) between unfed and fed fish at time 1.5 h, where fed fish show a higher 
CCK-N mRNA copy numbers than unfed fish (Figure 3.3.5; a). No significant differences 
were found in CCK-N mRNA expression in pyloric cecae (S4) (Figure 3.3.5; b). The midgut 
(S6) and hindgut (S9) are not presented for CCK-N as q-PCR results of CCK-N mRNA copy 
numbers were below the detectable limit for q-PCR. Results from main effect ANOVA using 
time (h) and fish groups (fed, unfed) as effects failed to show significant values at p<0.05. 
This was also the case for one-way ANOVA using time as independent factor for each fish 
group. 
 
 
Figure 3.3.5 CCK-N copy numbers in Atlantic salmon GI tract. CCK-N mRNA copy numbers are 
shown for stomach (a) and pyloric cecae (b). See caption in Figure 3.3.1 for information on data 
representation. Midgut and hindgut were not included in this figure as several fish spread over 
different time groups showed CCK-N mRNA expression below the detectable limit in q-PCR.   
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3.4 Results of correlation between sample Ct value and RIN 
Table 3.4 summarizes the results from the linear regression of sample Ct values and their 
corresponding RIN value obtained from q-PCR and RNA integrity assessment, respectively. 
All genes analyzed in pyloric cecae (S4) showed significant correlation at p<0.05. In midgut 
(S6); EF1α (reference gene), PYY and CCK-N showed significant correlation between Ct and 
RIN. In stomach (S2), GRLN-1 and GRLN-2 showed significant correlation with p values 
(<0.05). However in hindgut (S9), only CCK-L showed significant correlation (p<0.05). The 
coefficient of determination (r
2
) showed low values for all genes (r
2
<31). 
 
Table 3.4 Correlation between RNA integrity and cycle threshold (Ct). Results of Cycle 
threshold (Ct) values (y) plotted against RNA integrity (x). Data are represented for the 
different genes expressed in different segments of the GI tract (S2, S4, S6 and S9) showing; 
coefficient of determination (r
2
) and regression p value. All samples underwent similar 
experimental treatment. Data were considered significant at α < 0.05, n.s. = non significant (α 
> 0.05). Significant values are shown in bold and underlined. 
 
 Stomach (S2) Pyloric cecae (S4) Midgut (S6) Hindgut (S9) 
 r2 p r2 p r2 p r2 p         
         
EF1α 0.091 
 
n.s. 
 
0.290 
 
0.002 
 
0.306 
 
0.001 
 
0.082 
 
n.s. 
GRLN-1 0.144 
 
0.033 
 
0.134 
 
0.040 
 
0.001 
 
n.s. 
 
0.025 
 
n.s. 
 
GRLN-2 0.135 
 
0.042 
 
0.143 
 
0.033 
 
0.035 
 
n.s. 
 
0.037 
 
n.s. 
 
PYY 0.056 
 
n.s. 
 
0.309 
 
0.001 
 
0.298 
 
0.001 
 
0.025 
 
n.s. 
 
CCK-L 0.001 
 
n.s. 
 
0.146 
 
0.031 
 
0 
 
n.s. 
 
0.172 
 
0.018 
 
CCK-N 0.003 
 
n.s. 
 
0.210 
 
0.008 
 
0.174 
 
0.048 
 
0.047 
 
n.s. 
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4. Discussion 
4.1 Spatial mRNA expression of GI tract peptide hormones in Atlantic salmon 
4.1.1 GRLN-1 and GRLN-2  
The GI tract has been shown to be the main site of GRLN production in all vertebrates 
studied to date (Kaiya et al. 2008). This recently included Atlantic salmon (Murashita et al. 
2009). The current study showed that GRLN-1 and GRLN-2 is expressed throughout the GI 
tract in Atlantic salmon (Figure 3.2.1 and 3.2.2) which correlates well with results from 
studies in other vertebrates (Kaiya et al. 2008; Murashita et al. 2009). GRLN-1 and GRLN-2 
were both highest expressed in the stomach, moderately expressed in pyloric cecae and 
midgut, and lowest expressed in hindgut. No differences were found between GRLN-1 and 
GRLN-2 spatial mRNA expression, possibly indicating similar functions. The high levels of 
GRLN in Atlantic salmon stomach observed in the present study, is in agreement with 
previous studies in Atlantic salmon, rainbow trout, eel, catfish, tilapia (Murashita et al. 2009) 
(for more details on species comparison see; Kaiya et al. 2008).  
In the current study, apparently higher GRLN mRNA expression for the two GRLN 
isoforms were found in pyloric cecae, midgut and hindgut compared to results presented in 
Murashita et al. (2009). In their work, Murashita et al. (2009) did not detect GRLN mRNA 
expression in Atlantic salmon hindgut after 32 amplification rounds using real time (RT)-
PCR. However as RT-PCR results of GRLN expression in Atlantic salmon hindgut are only 
semi-quantitative, a direct comparison of the results should be avoided (Murashita et al. 
2009). In addition fish size and consequently life stage differs and there may be physiological 
differences in the expression between juvenile fish in the present study and adult fish in 
Murashita et al. (2009).  
In immature rainbow trout, regional studies on GRLN mRNA expression in the GI 
tract also showed a moderate GRLN expression in the intestine, but low expression in pyloric 
cecae (Kaiya et al. 2003a). GRLN mRNA expression has not been investigated in adult 
rainbow trout, however moderate GRLN levels in immature Atlantic salmon and rainbow 
trout could imply life stage differences in GRLN expression. Although high expression of 
GRLN in stomach was found in all fish studied by Kaiya et al. (2003a) one of the fish 
expressed very low levels of GRLN mRNA in the intestine. Thus, individual differences 
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GRLN expression may also be a factor to be considered when performing tissue distribution 
studies on GRLN. A moderate expression of GRLN in midgut and hindgut of Atlantic salmon 
thus agrees with studies in rainbow trout, but contrasts former studies in Atlantic salmon 
(Kaiya et al. 2003a; Murashita et al. 2009). The higher mRNA expression of GRLN in pyloric 
cecae compared with hindgut agrees with Murashita et al. (2009). In contrast, rainbow trout 
show significantly lower GRLN expression in pyloric cecae, indicating species specific tissue 
distribution of GRLN in salmonids.  
Comparative studies in fish show high to moderate levels of GRLN in the intestine of 
eel, catfish, goldfish, and rainbow trout (Kaiya et al. 2008). Goldfish lacks a stomach, 
however the intestine was shown to be the main site of GRLN expression in this species 
(Unniappan et al. 2002). GRLN was not detected in the intestine of tilapia (Kaiya et al. 
2003c). The degree of GI tract compartmentalization in the form of a well demarcated 
stomach may thus influence the tissue distribution pattern of GRLN. In general, GRLN is 
expressed in high levels in the stomach of fishes and in high to moderate levels in the 
intestine. However there are species specific variations and individual variations in GRLN 
tissue distribution, thus possibly indicating species specific functions of GRLN in GI tract. In 
addition developmental life stage may also influence the spatial GRLN distribution. 
No differences in GRLN expression were found between fed and unfed fish groups. 
As these groups (fed/unfed fish) show the group average result of GRLN expression within 24 
hours, there may not be a direct effect of GRLN-1/2 on the entire fish group. However 
potential short term effects of GRLN-1/2 on regulating digestion and appetite within this 
period may still exist, and will be discussed more in depth in section 4.2 and 4.3.  
The specific function of GRLN in different areas of the GI tract is currently unknown. 
The higher expression in stomach of Atlantic salmon, suggest this region to be the most 
important in GRLN function. Intraperitoneal (IP) injections of GRLN have been shown to 
increase appetite in goldfish, while no effect was observed in rainbow trout (Unniappan et al. 
2004; Jönsson et al. 2007). It is thus uncertain if GRLN act as an orexigenic factor in fish as 
observed in mammals (Kojima and Kangawa 2002). Studies in mammals suggest that GRLN 
mediate its main effects through vagal afferents and not through circulating levels (Date et al. 
2002). Locally produced GRLN in the GI tract may thus have a more direct role in mediating 
the function of GRLN, in contrast to GRLN released into the circulation. The regional 
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distribution of GRLN in Atlantic salmon show similarities with rainbow trout, and thus 
indicates similarities in GRLN function in salmonids. This could include the effect of GRLN 
on appetite.  
It is also possible that GRLN produced in the GI tract is released into the circulation 
and affect distant targets. IP injections of GRLN have been shown to increase circulating 
levels of GH in goldfish, channel catfish, rainbow trout and tilapia (Kaiya et al. 2003a; 
Unniappan and Peter 2004; Kaiya et al. 2005; Fox et al. 2007). GRLN synthesized and 
secreted by endocrine cells in the stomach and intestine may thus bind to GHS-R receptors in 
the pituitary and stimulate GH release. GHS-R receptors in salmonids have been identified in 
the pituitary of rainbow trout (Kaiya et al. 2009). It would thus be interesting to study GHS-R 
receptors in Atlantic salmon. 
4.1.2 PYY  
The highest expression of PYY mRNA was found in pyloric cecae and midgut, while 
lower levels were detected in hindgut and stomach (Figure 3.2.3) in accordance with 
Murashita et al. (2009). In contrast to Murashita et al. (2009), this study accurately quantifies 
regional PYY mRNA expression in Atlantic salmon GI tract.  
Recently, Sundström et al. (2008) suggested a renaming of PY to PYYb. This naming 
will thus be used in this discussion as recommended in Murashita et al. (2009). Phylogenetic 
studies separate PYY into PYYa and PYYb type groups (Murashita et al. 2009). Atlantic 
salmon PYY is classified as PYYa type (Murashita et al. 2009). Semi-quantitative RT-PCR 
studies in tiger puffer fish (Takifugu rubripes) detected apparently high levels of PYYa and 
PYYb mRNA expression in intestine, similar to this current study (Sundstrom et al. 2008). 
However, Sundström et al. (2008) does not show the spatial tissue distribution of the two 
PYY types within the intestine. Quantitative spatial expression studies should thus be 
executed in tiger puffer fish in order to conclude on any similarities in PYYa expression with 
Atlantic salmon PYY. Q-PCR studies in yellowtail found high mRNA expression of PYYb in 
anterior intestine, -and lower expression in pyloric cecae, stomach and posterior intestine 
(Murashita et al. 2006). Although yellowtail PYYb belongs to the second teleost PYY group, 
PYYb show similar expression pattern with Atlantic salmon PYY in anterior intestine. 
However Atlantic salmon show higher levels of PYY mRNA in pyloric cecae, suggesting a 
species specific pattern of PYY mRNA expression.  
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In conclusion, studies on PYYa and PYYb distribution in fish GI tract all show a 
higher mRNA expression in anterior intestine and lower expression in stomach and hindgut. 
This is in contrast to mammals where PYY secreting cells are concentrated in distal intestine 
(Lundberg et al. 1982). Different expression patterns of PYY between fish and mammals 
suggest species specific functions of PYY in the GI tract. Also, the similarities in tissue 
distribution of PYYa and PYYb in fish possibly suggest similarities in function.  
In the current study fed fish exhibits higher PYY mRNA expression compared to 
unfed fish in stomach (Figure 3.2.3). In conclusion, this may indicate a potential effect of 
PYY during feeding in Atlantic salmon, however this effect is minor as no temporal 
differences were observered in PYY mRNA expression in stomach during meal processing 
(Figure 3.3.3; a). The postprandial effect of PYY is discussed under section 4.3 and 4.4.  
4.1.3 CCK-L and CCK-N 
This study demonstrated differences in the regional distribution for CCK-L and CCK-
N in Atlantic salmon GI tract. This was only indicated semi-quantitatively by Murashita et al. 
(2009). In the current study, CCK-L mRNA expression was detected in all GI tract regions 
studied (Figure 3.2.4). The highest expression of CCK-L mRNA was found in hindgut, 
whereas moderate expression was detected in midgut and pyloric cecae, and lowest 
expression in stomach. All results are in agreement with Murashita et al. (2009). Although 
CCK-L were only presented semi-quantitatively by Murashita et al. (2009), the band intensity 
are consistent with our results. In agreement with our results, Jensen et al. (2001) found high 
levels of trout CCK-L expression in anterior intestine and distal intestine. However, trout 
expresses higher levels of CCK-L in stomach and low levels in pyloric cecae. This finding 
contrast our results. A species specific distribution of CCK-L may thus exist in salmonids.  
In this study, CCK-N mRNA expression was detected in stomach and pyloric cecae, 
while the expression of CCK-N in intestine showed low or no detectable levels (Figure 3.2.5). 
The low expression in intestine is in agreement with semi-quantitative results presented by 
Murashita et al. (2009). In contrast to Murashita et al. (2009), equal CCK-N levels were 
detected in stomach and pyloric cecae in this current experiment. Murashita et al. (2009) did 
not find expression of CCK-N in stomach, however the differences in assay specifications and 
fish size could have influenced this result (as previously discussed for GRLN). Thus, the use 
of more sensitive methodology in the present study seems to have enabled the detection of 
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CCK-N in stomach. All together, this may indicate that stomach and pyloric cecae are the 
main sites of CCK-N production in Atlantic salmon GI tract. Semi-quantitative studies in 
rainbow trout show apparently no CCK-N in rainbow trout stomach in contrast to our results 
(Jensen et al. 2001). CCK-N was mainly expressed in pyloric cecae in rainbow trout (Jensen 
et al. 2001).  In conclusion, the results suggest an important role for CCK-N in pyloric cecae 
and possibly also in stomach of salmonids.    
Studies in both rainbow trout and Atlantic salmon demonstrate different expression 
patterns for CCK. While CCK-L shows expression throughout the gut in both species, CCK-
N is expressed mainly in pyloric cecae (and stomach in Atlantic salmon). The difference in 
regional expression between CCK-L and CCK-N may indicate specific roles including 
regulation of digestion and appetite. In addition, CCK-T which is found in trout was 
expressed in high levels in middle regions of the small intestine (Jensen et al. 2001). This 
could indicate the presence of additional CCK isoforms also in Atlantic salmon. In contrast to 
rainbow trout, Atlantic salmon exhibit higher expression of CCK-L in pyloric cecae, and 
CCK-N in stomach. Rainbow trout on the other hand expresses higher levels of CCK-L in 
stomach compared to Atlantic salmon. These results indicate species differences in the 
regional expression of CCK in salmonids.  
In conclusion, the expression of CCK isoforms found in Atlantic salmon GI tract in 
the current study, agrees with previous studies indicating roles for CCK in inhibition of 
gastric emptying, inducing gallbladder contraction and stimulating pancreatic secretion 
(Aldman and Holmgren 1995; Einarsson et al. 1997).    
Altogether this point to a difference in mRNA expression of GRLN, CCK and PYY as 
chyme is transported through the different GI tract compartments after feed ingestion.  
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4.2 Temporal changes in GI tract filling of feed and chyme, and gallbladder 
content in Atlantic salmon 
In fed fish almost all ingested feeds was still present in the stomach 0.5 h after the 
termination of the meal (=hours past feeding, hpf) (Figure 3.1.1; a). Thereafter there was a 
rapid response in emptying of stomach content. These results demonstrate that the ingested 
feed are kept in the stomach for gastric digestion, and then emptied to proximal intestine for 
digestion and absorption by a gradual regulated mechanism. It is interesting to note that at 0.5 
hpf when very little transfer apparently had taken place from stomach, the gallbladder was 
already nearly empty (Figure 3.1.2; a). At this time point minimal content was present in 
proximal intestine and pyloric cecae (Figure 3.1.1; a). Thus, the gallbladder appears to 
contract and release bile when feed is present in the stomach prior to significant chyme entry 
in the proximal intestine. These results may indicate feed-forward response of bile release in 
response to feed present in the stomach. This feed-forward response is possibly mediated by 
hormones in the stomach stimulated by luminal factors. In this current experiment all peptide 
hormones were expressed in stomach. The role of GI tract peptide hormones in regulating 
digestion will be discussed under section 4.3.  
At 1.5 hpf, the stomach was still filled with feed and chyme, a time point characterized 
by an empty gallbladder. The gallbladder volume did not seem to increase before 9 hpf, and 
reached prefeeding levels only between 12-24 hpf. It is important to notice that the 
relationship between gallbladder volume/mass and secretion rates is more complex than what 
can be interpolated directly from the presently available data. The gallbladder weight (Figure 
3.1.3; a) indicates that no bile is released into intestine from gallbladder from 1.5 hpf to 12 
hpf, a period characterized by gastric evacuation. The emulsification of lipids in this period 
may thus take place by; 1) residues of bile still present in the intestine, 2) bile originating 
from other organs, or 3) re-circulation of bile absorbed in the distal intestine and transferred 
by circulation to proximal intestine via liver and directly secreted through the Ductus 
choleductus. It may be possible that a combination of these mechanisms exist in GI tract. The 
presently available data suggest that the hormonal regulation of gallbladder contraction 
mainly seems to occur within 1.5 hpf which represents the intestinal phase of digestion.       
The gradual slower increase in luminal content in pyloric cecae, midgut and hindgut 
compared to stomach (Figure 3.1.1; a), imply a gradual transit of feed into intestine which 
most likely optimizes the capacity of intestine to digest and absorb nutrients. It is known that 
Discussion                                                                          
 
 
55 
 
gastric emptying takes place when the resistance to the flow of chyme through the pyloric 
sphincter and intestine is overcome (Olsson et al. 1999). A decrease in stomach content also 
allows ingestion of more feed and return of appetite. The current data for Atlantic salmon 
showed a concomitant increase in pyloric cecae content with decrease in stomach content, 
indicating gastric evacuation and relaxation of the pyloric sphincter. Although absorption and 
evacuation was not measured in this experiment, this may represent a loss of content observed 
in the graphs. The more gradual pattern of chyme filling observed in pyloric cecae, midgut 
and hindgut may thus include absorption. The pyloric cecae has been shown to absorb 50 % 
or more of amino acids, lipids and starch in Atlantic salmon and is thus considered to be the 
most important region for nutrient absorption (Krogdahl et al. 1999). However both proximal 
and distal intestine have also been shown to be involved in absorption (Krogdahl et al. 1999).  
Pyloric cecae serve to increase the absorptive area in fish and is surrounded by pancreatic 
tissue in Atlantic salmon (Buddington and Diamond 1987; Buddington et al. 1997). Filling of 
chyme into the cecae and mixing of chyme with pancreatic enzymes, have been suggested to 
occur by retrograde peristalsis in teleosts (Rønnestad et al. 2000). Taken together the observed 
increase of chyme in pyloric cecae at 0.5-9 hpf, together with reduction of overall content in 
the GI tract indicates release of pancreatic enzymes and absorption of nutrients.  
Studies on gut transit in rainbow trout using chromic oxide feed indicator 
demonstrated that an increasing fraction of the meal were present and processed in pyloric 
cecae and midgut from 3 hpf and it reached a maximum at 12 hpf (Sveier et al. 1999). 
Differences in experimental conditions and estimation of GI content may have caused the 
difference between the data of Sveier et al. (1999) and the present study. In our experiment, 
weight measurements of GI tract content were used to estimate the compartmental distribution 
and transfer of ingested food/chyme, while Sveier et al. (1999) used an indicator in the feed.  
One major limitation in the present study is the low water content in dry feed and the 
fluid balance that includes both swelling of the diets and release and absorption of fluids in 
the GI tract. The mass balance should therefore be done with precaution. Further, in the 
present experiment the content in pyloric cecae is not based on all the content in pyloric 
appendages as content was very difficult to remove from these cecae. The contents in the 
pyloric cecae were therefore probably underestimated (for more details, see Material and 
methods section). The fish used in the current experiment was ~45 g, while Sveier et al. 
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(1999) used ~695 g Atlantic salmon. The difference in fish size could also have caused a more 
rapid increase in content in proximal intestine and midgut in the current study.  
At the same time, the present data is a good indicator of GI tract compartment filling. 
There is normally a combination of enteroendocrine cells and neuronal sensing (chemical and 
stretch) of luminal content (nutrients and volume). The gut transit data in the present study 
could therefore be expected to give a good indication as to the progress of the digestive 
process, including the gastric and intestinal phases, and the interpretation of the spatial and 
temporal mRNA expression of the peptide hormones during processing of a meal. 
  Altogether the increase in pyloric cecae content at 0.5-9 hpf followed by increased 
content in midgut and hindgut (1.5-12 hpf), indicate an increased expression of peptide 
hormones regulating pancreatic secretion, gallbladder contraction and gut motility. All 
peptide hormones analyzed in this current study was expressed in pyloric cecae region, 
suggesting a possible role of these in controlling gut secretion and motility. CCK-N was not 
detected in midgut and hindgut, however it may have an endocrine intra-GI tract. This will be 
discussed under section 4.3. 
In the current experiment, all compartments were close to empty at 24 hpf, indicating 
the endpoint of digestion and evacuation of non digestible feedstuff and waste. This time scale 
is in agreement with Sveier et al. (1999). At this time the gallbladder weight is the same as 
prefeeding levels, indicating minimal digestion and refilling of the gallbladder. If GRLN, 
PYY or CCK are involved in regulating the digestive process, changes in expression could be 
expected to occur within the first 12-18 hours, when chyme is still present in GI tract.  
Gastric evacuation is thought to be a good predictor of the return of appetite (Grove et 
al. 1978). In their study it was estimated that gastric evacuation of 80-90% of stomach content 
corresponded to an increase in appetite in rainbow trout (Grove et al. 1978). In the current 
experiment 80-90 % of stomach content was evacuated between 12-24 hpf. GRLN, CCK and 
PYY have been shown to change in expression and plasma levels according to meal ingestion 
(Peyon et al. 1999; Batterham and Bloom 2003; Unniappan et al. 2004). In conclusion, 
potential anorexigenic peptide hormones (PYY, CCKs) are expected to increase within the 
initial 12 or more hours, while potential orexigenic peptide hormones (GRLN) are expected to 
increase when the stomach is close to empty (12-24 hpf) and increases appetite. 
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4.3 Postprandial changes of GI tract peptide hormones 
4.3.1 Postprandial regulation of digestion: GRLN-1 and GRLN-2 
The distribution of GRLN throughout the GI tract of Atlantic salmon may suggest a 
more direct effect on the digestive process other than stimulation of GH and appetite. Studies 
have shown that GRLN stimulate gastric acid secretion in mammals (Masuda et al. 2000). 
Previous studies have localized GRLN producing cells in gastric glands in rainbow trout, 
Japanese eel and summer flounder indicating a possible role in the regulation of gastric 
secretion (Sakata et al. 2004; Kaiya et al. 2006; Breves et al. 2009). It is however uncertain if 
GRLN regulates gastric acid secretion in fish. Gastric acid production has however been 
shown to be regulated by gastrin and histamine in the presence of luminal factors in fish 
(Buddington and Krogdahl 2004). In this current study, no postprandial changes in GRLN 
mRNA were detected during the first 12 hours of digestion including stomach (Figure 3.3.1 
and 3.3.2; a-d). The increase observed at 24 hpf in midgut and hindgut is concurrent with an 
empty gut (Figure 3.1.1, a). Together this may indicate an alternative mechanism of GRLN in 
regulating the digestive process. What should also be noticed is that the objective of the 
current study was to detect changes in mRNA expression. Thus possible effects of protein 
regulation are not included, but may exert an important step in GRLN regulation and function.   
Studies in mammals and birds show that GRLN have a motor effect in the gut (Peeters 
2005; Kitazawa et al. 2007). GRLN is structurally related to motilin which has a role in 
inducing the migrating motor complex (MMC) and accelerates gastric emptying in mammals 
(Vantrappen et al. 1979; Peeters 2005). MMC are spontaneous contractions which occur 
along certain patterns in the fasted state (Olsson and Holmgren 2001). Both the interstitial 
cells of cajal (ICC), the enteric nervous system and hormones have been implicated in the 
control of MMC (Olsson and Holmgren 2001). Studies in mammals recently suggested a role 
for GRLN in inducing MMC (reviewed by Peeters (2005)). Recently, both GRLN and motilin 
receptor genes were identified in the gut of zebrafish (Olsson et al. 2008). Although zebrafish 
do not have a stomach, immunohistochemical analysis detected GRLN receptor and motilin 
receptors throughout the gut of this species.    
A contradictory aspect of this should however be mentioned as is discussed by Peeters 
(2005). While plasma GRLN levels typically decreases rapidly after feeding as seen in 
goldfish (Unniappan et al. 2004), there may not be high enough levels of GRLN in the blood 
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to induce MMC which is a phenomena occurring between meals, or enough to induce gastric 
emptying (Olsson and Holmgren 2001). The effect is thus suggested to be mediated via 
paracrine actions of GRLN on vagal afferents, vagal efferents or the enteric nervous system 
(Peeters 2005). Studies in zebrafish detected GRLN receptor in all muscle layers of the gut 
(Olsson et al. 2008). It was also shown that both GRLN and motilin had excitatory effects on 
gut motility in this species. These results may thus suggest a possibly role for GRLN in both 
paracrine and endocrine excitation of gut muscle activity. 
In conclusion, the structural resemblance of GRLN and motilin, and the presence of both 
receptors in fish gut possibly indicate a role for GRLN in inducing MMC. The regional 
increase in GRLN mRNA expression observed in midgut and hindgut of fed fish when 
intestine is nearly empty (24 hpf) (Figure 3.1.1, a), and the effect of GRLN on fish gut 
motility strengthens the theory of GRLN involvement in MMC in Atlantic salmon. MMC has 
previously been described in trout and cod (Karila and Holmgren 1995; Olsson et al. 1999). 
GRLN mRNA expression did not increase at any of the time points in stomach or pyloric 
cecae region. Studies in zebrafish indicate a role for GRLN in motility throughout the GI tract 
(Olsson et al. 2008). However it is not possible to conclude on the regional effects of GRLN 
in Atlantic salmon. More studies should be conducted where the protein as well as the mRNA 
levels of GRLN is analyzed. Also, species specific responses may exist.  
4.3.2 Postprandial regulation of digestion: PYY  
PYY have been shown to have an inhibitory effect on pancreatic enzyme secretion, 
gallbladder release and intestinal motility in mammals (Batterham and Bloom 2003). In the 
current study, there was an increase in PYY mRNA expression at 1.5 hpf and a decrease at 3 
hpf in hindgut (Figure 3.3.3; d) which occurred concurrent to gastric emptying and transit of 
chyme into intestine (Figure 3.1.1; a). These results may thus indicate a postprandial effect on 
PYY mRNA expression in hindgut. The initial increase in PYY mRNA expression at 1.5 hpf 
may suggest a possible role for PYY in regulating the digestive process. At 3 hpf and 24 hpf 
PYY mRNA expression decreases, which may suggest the main postprandial effect on PYY 
mRNA levels take place before 3 hpf. At 1.5 hpf minimal content is present in hindgut. 
However, it is possible that initial transit of chyme during this period triggers a rapid and 
transient response in mRNA expression. At 3 hpf chyme content in the hindgut increased, 
however the transient response in mRNA expression appeared to be over. It is possible that 
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processing and secretion of PYY peptides takes place although no changes in mRNA 
expression were observed at 3 hpf. If so, this agrees with mammalian studies where chyme 
directly stimulate PYY producing L cells (Adrian et al. 1985).  
No postprandial changes in PYY mRNA expression were detected in stomach, pyloric 
cecae or midgut in Atlantic salmon in the present study (Figure 3.3.3; a, b and c). These 
results may however indicate an alternative mechanism of stimulating PYY mRNA 
expression other than direct stimulation by chyme. Studies in rats suggest a vagal stimulation 
of PYY producing L cells in the distal intestine by food in the proximal intestine (Fu-Cheng et 
al. 1997). In this study PYY plasma levels increased with peak values at 60 min after feeding, 
then decreased at 120 min. During this time food had not reached the PYY producing L cells. 
In the current experiment, PYY expression exhibits a similar short term response pattern after 
feeding. Thus, a vagal stimulation of PYY expression may be the case also in fish. However, 
future studies are needed to determine region specific response of PYY in Atlantic salmon.  
PYY mRNA expression may also be regulated by other GI tract peptide hormones. 
Murashita et al. (2008) demonstrate that PYYb mRNA levels in yellowtail decrease after 
feeding while CCK mRNA expression increases. This is opposite to mammals where CCK 
has been shown to stimulate PYY release in the distal gut in response to lipids in the proximal 
gut (Lin et al. 2000a). In the current study CCK-L and PYY show opposite responses in 
mRNA expression when comparing CCK-L mRNA at 0.5 hpf and 24 hpf in midgut and 1.5 
hpf in hindgut, with PYY mRNA in hindgut at the same time points (Figure 3.3.4; c, d and 
Figure 3.3.3; d, respectively). This could indicate an inhibitory effect of CCK-L in midgut and 
hindgut on PYY mRNA expression in hindgut. 
The physiological effect of these results on digestion may be an initial stimulation of 
CCK by food in midgut, shown by an increase in CCK-L expression concurrent with an 
increase in stomach and midgut content. Increased secretion of CCK may then exert its effect 
on pancreatic secretion, gallbladder contraction and increased intestinal motility. CCK may 
thus inhibit PYY-inhibition of these effects in the initial phase of digestion, optimizing the 
digestive process. In contrast to CCK-L, CCK-N mRNA expression increases in stomach at 
1.5 hpf. The different expression patterns of CCK-L and CCK-N may suggest different 
functions, also possibly in inhibition of PYY. It is possible that CCK and PYY are involved in 
a regulatory feedback loop in Atlantic salmon, similar to yellowtail (Murashita et al. 2008). 
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This feedback loop may possibly regulate the release of pancreatic secretion, gut motility and 
gallbladder contraction in response to feeding.  
4.3.3 Postprandial regulation of digestion: CCK-L and CCK-N  
The effect of CCK on digestion in Atlantic salmon has previously been described by 
Einarsson et al. (1997). In this study porcine CCK was IP injected and the release of 
pancreatic enzymes was measured. It was shown that CCK caused a dose dependent release of 
trypsin and chymotrypsin from the pancreas (Einarsson et al. 1997). In the present study 
CCK-N mRNA expression in stomach increased at 1.5 hpf, and mRNA levels of CCK-L in 
midgut increased at 0.5 hpf (Figure 3.3.5; a, and Figure 3.3.4; c, respectively). In this period, 
high content of feed and chyme was present in the stomach, and was also starting to be 
evacuated into pyloric region of intestine. The rapid increase in CCK-L levels, followed by 
CCK-N suggests a postprandial role in regulation of digestion, possibly involving secretion of 
pancreatic enzymes. Consequently, feed and chyme present in the GI tract may act in the 
direct stimulation of I-cells. Previous studies in mammals suggest that proteins present in the 
intestine serve as a substrate for proteases which normally degrades CCK-releasing factors 
(Liddle 1997). These studies may suggest that a similar mechanism exist in fish, with proteins 
in the feed indirectly stimulating CCK secretion.  
Previous studies in Atlantic salmon show that CCK has a stimulatory effect on 
gallbladder discharge (Einarsson et al. 1997). In the present study, the increased expression of 
CCK-N in stomach and CCK-L in midgut correlated with a decrease in gallbladder content 
(Figure 3.1.2; a). The increased CCK-L mRNA at 0.5 hpf in midgut, was concurrent with a 
rapid reduction in gallbladder content, while CCK-N in stomach increased at 1.5 hpf when the 
gallbladder was nearly empty. Thus, increased CCK-L mRNA expression and subsequent 
CCK secretion from midgut could have induced release of bile in Atlantic salmon. There may 
be differences in response time or function of different CCK isoforms in this species. 
Consequently, CCK-L appears to show a more rapid response compared to CCK-N, and may 
thus have a more rapid excitatory role on gallbladder discharge.   
In addition to potential stimulation of pancreatic secretion and gallbladder contraction, 
CCK may be involved in delaying gastric emptying. Studies in rainbow trout show that gastric 
emptying involves a lag phase before evacuation of chyme (Olsson et al. 1999). It was further 
demonstrated that IP injection of CCK-8 delayed gastric emptying, most likely by inhibiting 
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gastric motility and contracting smooth muscle cells in the pyloric sphincter (Olsson et al. 
1999). In this experiment, no direct measurements were performed on gut motility or gastric 
evacuation of feed. Measurements of content of feed and chyme in fish sampled at different 
time points after a meal does however give an indication of the anterograde movement of gut 
content through the GI tract. Based on previous studies in fish, peptide hormones like CCK 
are expected to have a role in regulating the motility required for digestion and transfer of 
feed and chyme also in Atlantic salmon. The increase observed at 0.5 and 1.5 hpf in 
expression of both CCKs correlates with high content of feed and chyme in stomach. It may 
thus be possible that CCK-N and/or CCK-L is involved in delaying stomach evacuation.   
It would be interesting to see the effect of IP injected Atlantic salmon CCK on motility 
patterns in the stomach and intestine of Atlantic salmon. It would also be interesting to 
identify how CCK mediates its effect in the GI tract. Olsson et al. (1999) suggest that CCK 
mediate its inhibitory effect on motility via a vago-vagal non-cholinergic pathway, while the 
excitatory effect of higher doses of CCK may be mediated via cholinergic pathways. Thus, it 
is good reason to believe that CCK mediates its effect by a similar mechanism in Atlantic 
salmon.   
 
4.4 Regulation of appetite: postprandial variation in GRLN, CCK and PYY 
mRNA expression 
4.4.1 GRLN-1 and GRLN-2 in appetite regulation 
GRLN has been shown to undergo periprandial variation and increases appetite in 
both mammals and goldfish (Unniappan et al. 2004; Cummings 2006). In rainbow trout and 
Mozambique tilapia the role of GRLN in regulating appetite is uncertain (Riley et al. 2005; 
Jönsson et al. 2007; Shepherd et al. 2007; Fox et al. 2009). In this experiment, no short term 
effect of feeding was observed for GRLN-1 and GRLN-2 in Atlantic salmon GI tract within 
the first 6 hours after feeding (Figure 3.3.1, 3.3.2; a, b, c, d). However, higher expression of 
GRLN-1 and GRLN-2 at 24 hours after feeding was found in midgut and hindgut (Figure 
3.3.1, 3.3.2; c, d). During this time period the stomach is almost empty, suggesting a possible 
return of appetite (Grove et al. 1978). The effect of increased GRLN at 24 hpf, could further 
indicate a role for GRLN in meal initiation in Atlantic salmon as observed for mammals, as 
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this time point is characterized by the normal scheduled feeding time (Cummings et al. 2001). 
More studies should be conducted to establish the effect of GI tract derived GRLN in 
initiating a meal in Atlantic salmon. 
Studies in Mozambique tilapia did not detect periprandial variation in GRLN mRNA 
expression in the stomach of this species (Fox et al. 2009). In this study, GRLN mRNA levels 
were measured at 0.5, 2, 10 and 24 hpf in the stomach. No differences were found between 
fed and unfed Mozambique tilapia in this study. However, Mozambique tilapia does not 
express GRLN in intestine (Kaiya et al. 2003c). An increase in GRLN expression in Atlantic 
salmon at 24 hpf in midgut and hindgut might thus be a species specific response due to 
physiological differences in GRLN expression.  
In contrast to what was observed in the present study, and for Mozambique tilapia, 
instant postprandial responses of GRLN mRNA was observed in goldfish (Unniappan et al. 
2004). In goldfish, GRLN undergoes periprandial variation in mRNA expression in the GI 
tract (Unniappan et al. 2004). Goldfish GRLN mRNA expression decreased at 1- and 3 hpf, 
suggesting an appetite stimulatory role for GRLN. It should be noticed that in contrast to 
Atlantic salmon and Mozambique tilapia, goldfish do not have a stomach. The study by 
Unniappan et al. (2004) measured the total GRLN mRNA expression in goldfish gut, lacking 
region specific analysis of GRLN expression.  
The previous discussion has focused on changes in GRLN mRNA expression. 
However, several studies report periprandial variation in GRLN plasma levels. Plasma levels 
of GRLN were not included in this experiment as the objective of this study was to detect 
changes in mRNA expression of peptide hormones. In goldfish, both GRLN expression levels 
and plasma levels decreased within 3 hours after feeding. However while unfed fish showed a 
slight decrease in GRLN expression an increase in plasma levels was observed within the 
same time scale. One possible explanation for this is that while expression studies of GRLN 
in gut tissue only detect differences in expression within the gut tissue, plasma levels 
represents GRLN produced by all tissues secreting GRLN into blood. The increase in plasma 
GRLN at time 0 in unfed goldfish, which indicate the normal scheduled feeding time, could 
thus suggest a role for GRLN in meal initiation.  
However, Fox et al. (2009) reports no significant periprandial changes in plasma 
GRLN levels in Mozambique tilapia, concurrent with no changes in GRLN mRNA 
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expression. Also, no postprandial changes in plasma GRLN levels were observed for rainbow 
trout (Jönsson et al. 2007). No mRNA levels of GRLN are available for rainbow trout in the 
study of Jönsson et al. (2007). Although no short term effect was observed in GRLN mRNA 
expression in Atlantic salmon, studies in tilapia and rainbow trout indicate no postprandial 
change in GRLN plasma levels. However, since GRLN may exert its appetite effect through 
direct activation of vagal afferents, the measurements of mRNA expression might have 
indicated an effect not detected by assessment of GRLN plasma levels (Date et al. 2002). All 
together, the lack of short term postprandial changes in GRLN mRNA expression in Atlantic 
salmon indicates that GRLN may not be synthesized as mRNA by the GI tract to mediate 
short term regulation of feeding.  
In addition to a role in appetite, IP injections of GRLN have been shown to stimulate 
the GH/IGF-1 axis in several fish species (Kaiya et al. 2003a; Unniappan and Peter 2004; 
Kaiya et al. 2005; Fox et al. 2007). Stimulation of the somatotrophic axis is however mediated 
through circulation. It is possible that GRLN has a similar role in Atlantic salmon, thus 
linking short term meal signals to longer term energy balance. Measurements of plasma 
GH/IGF-1 in rainbow trout, suggest no direct effect of GRLN on GH release (Jönsson et al. 
2007). In this study GH levels were elevated in fasted fish, while plasma GRLN levels were 
suppressed. The lack of effect of GRLN in stimulating GH release may thus be a salmonid 
adaption.  
4.4.2 CCK-L and CCK-N in appetite regulation 
Postprandial increase in CCK-L mRNA expression was detected at 0.5 hpf (midgut), 
while a decrease was observed at 1.5 hpf (hindgut), 3 hpf (stomach) and 24 hpf (midgut). 
CCK-N mRNA expression was increased in stomach at 1.5 hpf. Altogether the results indicate 
a short term postprandial effect of CCK-L and CCK-N in Atlantic salmon GI tract. CCK has 
previously been shown to control appetite as a satiety signal in mammals (Gibbs et al. 1973; 
Chandra and Liddle 2007). However, little research on the role of CCK in regulating appetite 
in fish exists. Studies in goldfish and rainbow trout suggest a role for CCK in inhibiting 
appetite in these species (Himick and Peter 1994; Gelineau and Boujard 2001). In goldfish, 
CCK IR was detected in brain (including hypothalamic areas) and in anterior gut on nerve 
fibers and endocrine cells (Himick and Peter 1994). IP injection of sulphated CCK-8 in 
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goldfish decreased food intake in a dose dependent manner (Himick and Peter 1994). 
Altogether these studies suggest a role for peripheral CCK in decreasing food intake.  
It has previously been shown in rainbow trout that CCK is released in response to an 
acidification of the proximal intestine and the presence of proteins and fats (Aldman and 
Holmgren 1995). Thus, it is possible that secreted CCK mediates a satiety action in 
salmonids. 
In this current experiment, CCK-L showed higher expression in fed fish compared to 
unfed fish in midgut at 0.5 h after feeding. Himick and Peter (1994) demonstrate an 
immediately decrease in food intake when goldfish receive IP injection of CCK-8 30 min 
after feeding. Although feed intake was not monitored in this current experiment, an increase 
in CCK-L mRNA expression in Atlantic salmon midgut 30 min after feeding suggest a similar 
satiety action in these species. A higher mRNA expression of CCK-L was also observed in 
midgut at 24 hpf. At this time point, minimal chyme was present in this region. The potential 
role for increased CCK-L in regulation appetite at this time point is thus uncertain. In contrary 
to midgut, CCK-L exhibited no postprandial change in mRNA expression in Atlantic salmon 
hindgut at 0.5 hpf, and decreased at 1.5 hpf. Although CCK-L was expressed in low levels in 
stomach, a decreased mRNA expression was detected at 3 hpf. In conclusion, these results 
require further studies.                                                                                                               
Although CCK-N exhibits a different regional tissue distribution than CCK-N, 
similarities exist in the postprandial regulation with respect to time. CCK-N mRNA levels 
were higher at 0.5 hpf, but instead of midgut tissue, this elevated expression was found in 
stomach tissue. Again this points to a region specific response for the different CCK isoforms. 
The elevation in mRNA expression of both CCK isoforms shortly after feeding, suggest a role 
for CCK as a satiety signal in Atlantic salmon. It is possible that CCK-N mediates a potential 
satiety effect in stomach in response to stomach filling. In contrast, CCK-L may possibly 
serve as an intestinal satiety signal, stimulated when food and chyme enters the midgut. 
Although the stomach is filled with chyme at 0.5 hpf, the increase in CCK-N in stomach at 
1.5 hpf may provide a lag phase prior to mediating a potential satiety effect. In all cases CCK 
expression decreased at 3 hpf, indicating a rapid postprandial effect (within 1.5 hours) on 
mRNA expression.  
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In an experiment, rainbow trout were fed capsules containing CCK-1 receptor 
antagonist (Gelineau and Boujard 2001). The study showed a significant increase in appetite 
in fish provided CCK-1 receptor antagonist, indicating a role for CCK as a satiety signal 
trough CCK-1 receptors in rainbow trout. The present study is to our knowledge the first 
study that aims to describe the postprandial mRNA expression of CCK in GI tract of Atlantic 
salmon. It is possible that CCK have a satiety effect in Atlantic salmon similar to goldfish and 
rainbow trout. It is also unknown whether the distribution of CCK-1 receptors is similar for 
Atlantic salmon and rainbow trout. However, the two salmonid species show differences in 
regional CCK mRNA expression (as previously described). If the satiety effect of CCK is 
mediated through CCK-1 receptors on vagal afferents in Atlantic salmon as described for 
mammals, it may be activated by nearby CCK producing cells (Raybould 2007). It is thus 
possible that a region specific activation of CCK receptors and satiety exists for Atlantic 
salmon. As CCK mediates its satiety effect through CCK-1 receptors in mammals and trout, 
knowledge on tissue distribution of this receptor in Atlantic salmon would be valuable in 
describing the mechanism CCK mediates its action (Gelineau and Boujard 2001; Chandra and 
Liddle 2007).       
4.4.3 PYY in appetite regulation 
The physiological role of PYY on appetite regulation is not known for fish. However, 
the available information of PYY in regulating food intake is derived from mammalian 
studies. In mammals, PYY is characterized as a satiety signal based on a preprandial decrease 
and a postprandial increase in plasma concentration (Ueno et al. 2008). Both intravenous 
infusion and chronic administration of PYY1-36 in mammals decrease food intake (Batterham 
et al. 2003). In mammals plasma levels of PYY begin to rise within 15 min of the start of 
eating, with peak values within 90 min (1.5 hpf), and high levels kept until 6 h after a meal 
(Adrian et al. 1985).  
A short term postprandial increase in PYY levels in mammalian hindgut 1.5 hpf is in 
agreement with our results. This could indicate a role for PYY in mediating a satiety effect 
from the hindgut of Atlantic salmon. The rapid response in PYY mRNA levels 1.5 hpf in 
hindgut may possibly have provided an appetite regulating signal in the form of increased 
PYY secretion. However, these results require future studies. The lack of postprandial effect 
on PYY mRNA levels in stomach, pyloric cecae or midgut may indicate a region specific 
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response to feeding within the GI tract. Although minimal chyme content were observed in 
hindgut at 1.5 hpf, chyme present in proximal pyloric cecae region could have initiated a 
neuronal signal which further stimulates PYY secreting cells in hindgut as seen in mammals 
(Fu-Cheng et al. 1997). The decrease in PYY expression observed at 3 hpf in hindgut, could 
however not be explained by this hypothesis as chyme is still present in proximal intestine at 
this time point. Consequently, PYY may thus initiate a rapid response to feeding within 1.5 
hpf in Atlantic salmon. 
Although fish PYYb belongs to a different phylogenetic group than fish PYYa, they 
both originate from a common PYY ancestor gene (Larhammar 1996; Murashita et al. 2009). 
The similar tissue distribution pattern between Atlantic salmon PYYa and yellowtail PYYb 
could imply similar physiological functions (Murashita et al. 2006; Murashita et al. 2009). 
Murashita et al. (2006) found decreased PYYb expression in anterior intestine of yellowtail 3 
hpf, compared to fish fasted for 72 h. No such differences were found in this current 
experiment in anterior intestine of Atlantic salmon. This could indicate a species specific 
response to feeding by PYY. At time 3 h in this current experiment, unfed fish was fasted for 
27 h, and maximum hours of fasting was 48 hours. Thus, differences in the experimental 
conditions could have affected the difference in results. In the yellowtail experiment only 3 
hpf-fish were sampled, lacking a postprandial time scale. However, the lower expression of 
PYYb in fed yellowtail indicates an opposite effect in response to feeding compared to 
mammals (Murashita et al. 2006).   
In conclusion, very limited knowledge exists on the effect of nutrient intake on PYY 
expression in fish. It is possible that PYY signals a satiety signal via Y2 receptors to 
hypothalamic brain centres involved in appetite regulation as is the case in mammals 
(Batterham et al. 2002). Recently NPY-receptors were identified in rainbow trout (Larsson et 
al. 2006). This study showed that Y7 receptors were more abundant in the intestine than Y2 
receptors which were most abundant in gills. PYYa and PYYb bound to both receptors, 
indicating that PYY produced in GI tract signals through Y7 receptor. This also strengthens 
the theory of similar functions of PYYa and PYYb.  No information exists on the effect of 
this binding. It is possible that Atlantic salmon PYY binds to nearby intestinal Y7 receptors in 
a paracrines manner if these receptors exist in this species. It is also possible that PYY 
produced in the intestine is transferred by the blood and binds to Y2 receptors on gills or 
distant targets including brain areas involved in feeding regulation.  
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4.5 Circadian variation in GRLN-1, GRLN-2, PYY, CCK-L and CCK-N 
Food availability and meals can act as a powerful zeitgeber capable of synchronizing 
many biological rhythms in fish (SanchezVazquez et al. 1997). Goldfish synchronized to 
feeding at a particular schedule, overcame variations in light cycles and altered their activity 
pattern according to meals (SanchezVazquez et al. 1997). GRLN has been shown to change in 
a diurnal pattern in mammals, with levels rising throughout the day to a zenith at 01.00, then 
falling overnight to 09.00 (Cummings et al. 2001). In this experiment fish were fed once a day 
at the same time of day in two weeks prior to sampling. This period should have acclimated 
the fish to the feeding regime. Unfed fish were subsequently fasted for 24 hours prior to 
sampling. Results from the assessment of GI tract compartment filling and gallbladder content 
in unfed control group, show an empty GI tract (Figure 3.1.2; b) and gallbladder with overall 
high content (Figure 3.1.3; b) throughout the experimental period. Minimal effects of feed 
should thus have influenced the expression of the analyzed genes. The results from this 
current study showed no statistical effect of time alone on mRNA copy numbers of peptide 
hormones in unfed fish. Consequently, these results indicate minimal effect of diurnal 
rhythms on mRNA expression patterns of GI tract peptide hormones in Atlantic salmon. 
Although not statistical significant, the expression of GRLN-1, GRLN-2, PYY, CCK-L and 
CCK-N in unfed fish shows minor variations in expression over time. In pyloric cecae, CCK-
L expression increases from time 0 h (fish fasted for 24 hours) to 0.5 h. Thus, CCK-L may be 
an exception compared to the other genes. It is also possible that a circadian rhythm apart 
from a 24 h-profile exist in fish. However, in order to detect potential diurnal expression 
patterns, or alternative circadian profiles of GI tract derived peptide hormones, further studies 
are needed. In conclusion, no clear effect of diurnal rhythm on mRNA expression levels of GI 
tract peptide hormones was detected in Atlantic salmon.   
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5. Concluding remarks and future perspective 
5.1 Concluding remarks 
5.1.1 Spatial distribution of peptide hormones in Atlantic salmon GI tract 
GRLN-1 and GRLN-2 expression was found throughout the GI tract in Atlantic 
salmon. Both isoforms exhibited the same spatial distribution. The highest GRLN expression 
was found in stomach, as seen in previous studies in vertebrates. Moderate expression was 
detected in pyloric cecae and midgut, and lowest expression was found in hindgut. PYY was 
expressed in all segments of the GI tract. The highest PYY expression was found in pyloric 
cecae and midgut, moderate expression in hindgut and lowest expression in stomach. CCK-L 
and CCK-N exhibits different tissue expression patterns, suggesting different functions in 
Atlantic salmon (see Figure 5.1). CCK-L exhibited highest mRNA levels in hindgut, with 
slightly lower expression in pyloric cecae and midgut. The lowest CCK-L expression was 
detected in stomach. CCK-N is mainly expressed in the stomach and pyloric cecae region, 
while only low expression levels were detected in midgut and hindgut. The spatial expression 
patterns of peptide hormones suggest involvement in regulation of digestive process and 
appetite. 
5.1.2 Gastric filling and evacuation, GI tract transit of feed and chyme, and 
gallbladder release in Atlantic salmon 
 The stomach of Atlantic salmon was filled with feed and chyme at 0.5 hpf, shortly 
followed by gastric evacuation mainly between 0.5-12 hpf. At 24 hpf the stomach was empty. 
Pyloric cecae, midgut and hindgut show more gradual changes in content, indicating a 
regulated emptying of stomach content, and absorption of nutrients, however not assayed. At 
24 hpf all GI tract compartments are empty, indicating the end point of digestion. The 
immediate release of gallbladder content within 0.5-1.5 hpf, suggest a rapid excitation of 
gallbladder contraction possibly induced by chyme in the proximal intestine or feed in the 
stomach. In conclusion these results indicate that the digestive process in Atlantic salmon is 
highly regulated by synchronizing events such as; gastric evacuation, GI tract peristalsis, 
digestive secretion, absorption and evacuation of non-digestible feed. GI tract peptide 
hormones are expected to be involved in this regulation. 
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5.1.3 Postprandial changes in mRNA expression of GI tract peptides and the possible 
involvement in regulating the digestive process and appetite in Atlantic salmon 
Both CCK-L and CCK-N mRNA levels increased within 1.5 hpf in midgut and 
stomach, respectively, concurrent with an increase in feed and chyme in stomach and a 
decrease in gallbladder weight. This supports a possible role for CCK in regulating gastric 
evacuation, pancreas secretion and gallbladder contraction in Atlantic salmon (Figure 5.1). In 
addition, it is also possible that an increase in CCK mRNA expression in response to feeding 
is to mediate a satiety signal from the gut to the brain (Figure 5.1). PYY mRNA expression 
increases in 1.5 hpf, then decreases at 3 hpf. In this period chyme is evacuated into the pyloric 
region and is also present in midgut and hindgut, while the gallbladder is empty. These results 
support a role for PYY in regulating the digestive process, possibly involving GI tract motility 
and digestive secretion. In addition, PYY may also regulate appetite in Atlantic salmon 
(Figure 5.1). GRLN mRNA expression is not increased before 24 hpf, a time point 
characterized with minimal content of feed and chyme in the GI tract. Thus, GRLN may not 
have a short term postprandial effect on digestion, but may have a between-meal effect related 
to regulation of GI tract motility and a role in meal initiation (Figure 5.1). The mRNA 
expression results of CCK and PYY may further suggest that these peptide hormones are 
involved in a regulatory feedback loop where CCK possibly inhibits PYY. Consequently, 
CCK and PYY may have antagonistic effects on gallbladder contraction, pancreatic secretion 
and possibly GI tract motility in Atlantic salmon.  
5.1.4 Diurnal influences and possible suggestions of species specific effects on 
mRNA expression of GI tract peptide hormones in Atlantic salmon 
No clear diurnal rhythms were observed in mRNA expression of GRLN, PYY or CCK 
in unfed Atlantic salmon. However alternative circadian rhythms may still exist which may 
have a potential effect on GRLN, PYY and CCK mRNA levels or peptide levels. If this is the 
case, GRLN, PYY and CCK may be involved in long term energy homeostasis in Atlantic 
salmon.  
Several differences in results were detected between this current experiment and 
mammals, and also between other fish species. Goldfish has been used as an extensive model 
organism when studying the effect of appetite regulating hormones. This species is in contrast 
to Atlantic salmon an omnivorous temperate freshwater fish that usually lives under relatively 
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constant environmental conditions (Volkoff et al. 2009). Atlantic salmon is a carnivorous 
euryhaline aquaculture species adapted to seasonal changes in temperature and light 
conditions. As fish are a highly diverse group of ectothermic species, the surrounding 
environment will influence the different species in a higher degree than mammals. Thus the 
difference in habitats, feeding habits and response to feeding suggest a species specific 
endocrine regulation of digestion and appetite in Atlantic salmon.  
 
 
 
Figure 5.1. Suggested scheme of central and peripheral effects of gastrointestinal (GI) peptide 
hormones in Atlantic salmon based on their mRNA expression levels during processing of a 
single meal. See next page for legend (page 71). 
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Figure 5.1. Suggested scheme of central and peripheral effects of gastrointestinal (GI) peptide 
hormones in Atlantic salmon based on their mRNA expression levels during processing of a 
single meal. The GI tract is represented by four compartments including; stomach, pyloric region, 
midgut and hindgut with pancreas and gallbladder. The area between the stomach and pyloric region 
illustrates the pyloric sphincter and thus the control of gastric emptying. The origin site of the arrows 
represents a significant increase in mRNA expression of the representative peptide hormone in this 
compartment in the present experiment. The end of the arrow represents a suggested effect 
(stimulatory/inhibitory) of this peptide hormone on possible locations. Arrows arising and ending at 
the same target indicate local paracrines effects. The central effect of each peptide hormone is listed 
on top of the figure, while peripheral effects are listed on the bottom of the figure. Arrows pointing 
upwards next to a description indicates a possible stimulatory effect on this description, while arrows 
pointing downwards indicate a possible inhibitory effect. The dotted colored lines represent less 
supported effects. Colored lines crossing the dotted line running across the figure indicates indicate 
GI tract peptide hormones mediating a central effect on brain areas through vagal afferents or 
through the blood. The effect of GRLN (GRLN)- 1 and -2 are shown as one color coding (red) as no 
differences in mRNA expression were detected between the isoforms. MMC; migrating motor complex, 
GB; gallbladder, Secr.; Secretion, Contr.; Contraction. 
5.2 Future perspective 
The current study is the first extensive description of the postprandial changes in 
mRNA expression of GRLN, PYY and CCK in Atlantic salmon. The results of these changes 
was then related to gastric evacuation, gut transit of feed and chyme and regulation of 
gallbladder contraction hence bile release. The data also indicate some of the roles served by 
these peptide hormones in the regulation and optimization of digestion and appetite in 
Atlantic salmon. However, in order to achieve a clearer understanding of the roles of GI tract 
peptide hormones in Atlantic salmon, future research should aim to assess protein levels as 
well as plasma concentrations, in addition to gene expression analysis of GI tract peptide 
hormones. This will enable to assess both their endocrine and paracrines roles. In addition 
experiments should be conducted to obtain information concerning the local effect of different 
peptides in the GI tract and both in vivo and in vitro studies could be included. Both GRLN, 
PYY and CCK have been described as brain-gut peptides. In the brain, the gut derived signals 
are involved in multiple redundant pathways regulating feed intake in order to maintain 
energy homeostasis (Volkoff et al. 2009). The distribution of GHS-R, CCK-R and NPY 
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receptors should be assessed to increase the knowledge of the regional effect of GRLN, PYY 
and CCK within Atlantic salmon GI tract, and in additional tissues including brain areas.  
It would also be valuable to study the effect of both IP injected and centrally injected 
GRLN, PYY and CCK on appetite and digestion. In this case the use of recombinant peptides 
provides a valuable tool, not only in preparation of injections, but also by adding recombinant 
peptides into osmotic pumps. Insertion of osmotic pumps into Atlantic salmon can then be 
used to study the longer term (week-month) effects of peptide hormones on appetite and 
energy homeostasis, and potential alternative functions in this species. 
The pathways GRLN, CCK and PYY are involved in when mediating a signal should 
also be studied to increase the knowledge of the roles of each peptide hormone. It has 
previously been shown that GRLN mediate its appetite stimulatory action via the orexigenic 
NPY in the goldfish brain (Miura et al. 2006). Further, CCK has been shown to mediate the 
effect of leptin in goldfish (Volkoff et al. 2003a). In goldfish leptin potentiates the satiety 
effect of CCK, and a blocking of CCK receptors attenuate leptin inhibition of NPY induced 
feeding (Volkoff et al. 2003a). PYY have been shown to inhibit NPY induced feeding in 
mammals, but limited information of PYY exist for fish (Vincent and le Roux 2008).  
Several of the gut derived peptide hormones have been shown to respond differently 
according to meal composition and total calorie content. It should thus be of uttermost interest 
to the aquaculture industry to study the effect of feed with different compositions of proteins, 
lipids and carbohydrates on the digestive process and appetite in Atlantic salmon. An 
increased knowledge of the dynamic process of digestion and its complex regulation is needed 
in order to produce fish feeds with alternative ingredients that still maintain appetite and an 
efficient digestion in Atlantic salmon.   
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6. Methodological considerations 
6.1 Gene expression 
Q-PCR is considered to be the method of choice for detecting low abundance mRNA 
due to its high sensitivity (Bustin 2000). It is a highly sensitive method which may 
compromise the specificity of the reaction and detect false positives, as it does not distinguish 
between illegitimate transcripts and low abundance transcripts (Kwok and Higuchi 1989) 
.Several critical areas must be taken into consideration before analyzing the transcriptome 
such as; standardization of q-PCR protocols, assay design, reagents, template preparation and 
analytical methods (Freeman et al. 1999). In addition to operator variability; template quality, 
reverse transcription (RT) reaction and data analysis are all technical aspects which could bias 
the data interpretation (Bustin and Nolan 2004). The areas which will be discussed in this part 
include; sample acquisition, RNA isolation, DNase treatment, cDNA synthesis and qPCR. 
RNA quality and the reverse transcription reaction will be especially emphasized, as 
downstream results demands optimality of these factors. 
6.1.1 Sample acquisition and storage  
The first step towards qPCR is acquisition of biological material. The integrity and 
quality of RNA are the most critical determinants for reliable downstream qPCR results 
(Bustin and Nolan 2004). As RNA is unstable, the initial tissue preservation should be 
executed in a carefully manner. In this study, gut tissue were sampled quickly on dry ice after 
the removal of gut content. Samples wrapped in aluminum foil were then fresh frozen in 
liquid nitrogen. The frozen samples were kept at -80° C for storage. Prior to RNA isolation, 
samples were at all times kept on dry ice when not in -80° C freezer to avoid thawing. 
6.1.2 Assessment of RNA quantity, quality and integrity 
Prior to RNA isolation, tissue samples were weighed within a standardized range of 
40-45 mg ± 5 %. 10 % of the samples had equal to or below 36 mg as total weight, for these 
samples all of the tissue was used. To estimate total RNA quantity and to ensure pure RNA 
samples, all samples were analyzed using NanoDrop ND-1000 spectrophotometer (Thermo 
Scientific), measuring sample absorbance. The A260/A280 gives an estimate of the RNA to 
protein ratio. As proteins and phenol absorb strongly around 280 nm, an impure sample will 
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have a lower A260/A280 value. A value of ~2.0 is accepted as pure for RNA, though this 
value may be influenced by pH and ionic strength in solvent (Wilfinger et al. 1997). All RNA 
was dissolved in Nuclease-Free Water (Ambion) and found to have A260/A280 value > 2.0 
(results not shown). An overestimation of total RNA concentration may occur if DNA is 
present in the sample. This is caused by the absorbance of DNA at 260 nm (Imbeaud et al. 
2005). All samples were DNase treated prior to cDNA synthesis to ensure RNA of high 
quality and correct quantity to be submitted to cDNA synthesis. 
A secondary qualitative measure of A260/A230 was included for all samples. Both 
carbohydrates and phenol absorb at wavelength 230 nm, A260/A230 ratio should thus be 
above ~2.0-2.2 in order to classify a sample as pure (ThermoScientific 2009).All samples 
showed A260/A230 ratio above 2.2.  
Although the results from the A260/A280 and A260/A230 ratios indicate a good 
quality sample in terms of pure RNA, these values do not give an estimate of RNA quality in 
terms of integrity; hence “RNA intactness”. The RIN value obtained from Agilent 2100 
Bioanalyzer (Agilent Technologies) was thus used a superior RNA quality estimate. 
When handling RNA, RNases and long term storage under sub-optimal conditions can 
impair RNA integrity (Schoor et al. 2003). Thus, every RNA preparation should be tested for 
RNA integrity (Bustin and Nolan 2004). The RIN based Agilent method uses “state of the art 
technology”, and is the most objective way of assessing RNA integrity (Bustin and Nolan 
2004). Agilent 2100 uses microfluidic capillary electrophoresis technology, and in 
combination with a size standard, RNA bands can be estimated and contaminants ignored 
(Imbeaud et al. 2005).  A RIN value of 1 corresponds to a completely degraded sample and a 
value of 10 indicates a fully intact sample (Mueller et al. 2000). Degraded RNA can affect 
later Ct values in q-PCR (Raeymaekers 1993; Imbeaud et al. 2005). It is also shown that RIN 
values and Ct values possess a negative relationship, where typically degraded RNA with low 
RIN value show higher Ct values (lower expression), (Fleige et al. 2006; Schroeder et al. 
2006). A more fragmented sample demands a higher number of cycles to obtain cycle 
threshold. Fleige et al. (2006) suggest that all RIN values > 8 can be considered as optimal 
templates; RIN values 8 > 5 can result in sub optimal qPCR results, and degraded mRNA 
with RIN < 5 can interfere with PCR performance.  
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RIN values were obtained on all samples. 57 % of the samples showed partially 
degradation with total sample RIN average of 7.8 (±0.99 SD) (Appendix III, Figure AIII.2). 
There appeared to be a tissue/segment variation in RIN value, with stomach tissue having the 
most intact RNA with average RIN values of 8.9 (±0.68 SD). Tissue from pyloric cecae 
showed average RIN value of 7.0 (±0.53 SD). The midgut and hindgut both showed large 
variations within the group with average RIN values of 7.6 (±0.88 SD) and 7.5 (±0.76 SD), 
respectively (see Appendix III, Figure A.III.2). Consequently all samples were analyzed by 
linear regression plotting Ct values against RIN.  
Table 3.4 lists the r
2
 and p values of the linear regression, with p<0.05 considered 
significant correlation. The coefficient of determination r
2
, is used as a measure of the straight 
line relationship with r
2
=1, showing full explanation of the y value (Ct) by the regression line 
(Zar 1996). All genes analyzed in segment 4 (pyloric cecae) show significant p values at α = 
0.05, although the r
2
 show larger variation within the values for the different genes (Table 
3.4). For a graphical presentation of the linear regression for all genes, see Appendix III, 
Figure A.III.3-10. The pyloric cecae are intervened with pancreatic tissue in Atlantic salmon 
which produces several enzymes including RNase. What can also be seen in Table 3.2 is that 
r
2
 for PYY in pyloric cecae is higher compared with the other genes with 30.9% of variation 
in ct values explained by the regression line (p<0.05) followed by EF1α (r2=0.290, p<0.05). 
An r
2
 value of 0.309 should still be considered as a low value, indicating that the regression 
line explain the correlation between Ct and RIN for ~31% of the samples. These results are in 
contrast to the study executed by Fleige et al. (2006), where average r
2 
> 0.812. In contrast to 
pyloric cecae, the stomach, midgut and hindgut each show significant values only for a few 
genes. No single gene show significant values for all tissues (Table 3.2). Consequently, the 
effect of assay is thought to have minor influence of Ct/RIN correlation. In conclusion, the 
results indicate a tissue specific effect on RIN, which is in accordance with Fleige et al. 
(2006). Furthermore, results from linear regression of Ct and RIN in the current study do not 
show an obvious relationship of low quality RNA and high Ct values, with the possible 
exception of pyloric cecae. The use of sub optimal RNA in q-PCR does not appear to affect 
Ct results in a critical manner.   
On the basis of these findings, an experiment was set out to obtain the optimal 
sampling strategy for ensuring high quality RNA. In this experiment several GI tract sampling 
strategies were tested in both fed and unfed fish; 1) GI tract content were removed and tissue 
Methodological considerations                                                                           
 
 
76 
 
cut on dry ice, 2) GI tract content were removed on bench top (room temperature) and the 
tissue cut on dry ice, and 3) the GI tract were immediately transferred to RNA later® 
(Ambion, USA) where the content was removed and the GI tract cut into segments. The 
second sampling strategy is identical to the sampling strategy applied in the present study. 
The results from this experiment should hopefully indicate which sampling strategy gives the 
highest RNA quality, and will clarify whether the current sampling strategy is optimal when 
sampling GI tissue (Valen et al., in prep).        
6.1.3 Removal of genomical DNA 
In this study all samples were DNase treated, thus minimal traces of DNA should be 
present in sample prior to reverse transcription. The effect of this step is somewhat 
questionable as oligo-DT primers used in cDNA synthesis poly(A)
+
-selects mRNA. However, 
DNase treatment may have a negative effect on RNA integrity, hence RIN value (personal 
communication, Ann-Elise O. Jordal).   
6.1.4 Reverse transcription: Synthesis of cDNA  
The reverse transcription reaction was separated from the qPCR reaction and 
consequently the RNA- and DNA-dependent polymerases were added to different tubes. Also, 
leftover cDNA could be kept for long term storage. The conversion of RNA into single 
stranded cDNA is not a well understood step, and is considered to be the most uncertain step 
in gene expression analysis (Stahlberg et al. 2004). Sources of variation are; biological 
inherent variation in RNA, variable quality of RNA and hence stability, RNA template 
abundance, background nucleic acids, secondary and tertiary structure of mRNA, priming 
approaches and properties of the reverse transcriptase enzyme itself.  
In the current study, SuperScript™ III First-Strand Synthesis System for RT-PCR was 
used. The SuperScript III Reverse Transcriptase enzyme is a version of M-MLV RT which 
has less RNAse H activity, and is the better choice if full length cDNA are to be amplified 
(Bustin 2000). Oligo(dT), which poly(A)
+
-selects RNA, was used as primer in the cDNA 
synthesis. Oligo(dT) primers have the ability to maximize the number of mRNA molecules 
that can be analysed from a small sample of RNA (Bustin 2000). It is more specific than 
random priming, but as it requires full length RNA (with intact poly(A) tail), it can be less 
efficient when it comes to transcribing fragmented RNA (Bustin et al. 2005), especially 
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mRNA which is not intact in the 3‟ end (Kubista et al. 2006). As samples showed variable 
RIN values, different efficiencies in the RT step may be the case. However, as concluded 
earlier the use of sub optimal RNA in q-PCR does not appear to affect the Ct results in a 
critical manner.  
In order to minimize sample to sample variation, samples were run in duplicate 
reactions taken from the same DNase treated RNA pool. According to Stahlberg et al. (2004), 
both inhibition that affect reaction efficiencies, and efficiency deviation that cause variation in 
copy number are eliminated by running multiple reactions in cDNA synthesis and averaging 
the measurement results. Stahlberg et al. (2004) show that by splitting the samples before 
reverse transcription a two times higher accuracy in sampling error occur, than by splitting the 
samples in the qPCR step.  
A minus reverse transcriptase (-RT) control was included in each PCR run to check 
for genomic DNA contamination in the RNA sample. No signal was observed in the –RT, 
indicating minimal SYBR green background binding due to gDNA. To avoid variation caused 
by different stocks of reagents, reagents were pooled and then aliquoted to minimize stock-to-
stock variations as far as possible.  
6.1.5 Q-PCR  
For the qPCR reaction, SYBR green I based Power SYBR
®
 Green PCR Master Mix 
was used (Applied Biosystems). SYBR green I is a DNA binding dye, which binds in the 
minor groove of double-stranded DNA in a sequence independent way and the fluorescence 
increases over 100-fold when bound (Deprez et al. 2002). Melting curve analysis was 
performed to detect unwanted products (primer-dimers) that may occur because SYBR green 
I bind non-specifically to double-stranded DNA. By slowly increasing the temperature above 
Tm (melting temperature) of the amplicon, the fluorescence signal changes. Plotting 
fluorescence as a function of temperature can distinguish the characteristic peak of the 
product from artifacts that typically melt at lower temperatures (Bustin 2000). No primer-
dimers were detected for any of the assays. The threshold cycle fluorescence level was set 
manually to 0.010, above background noise and within the exponential phase for all qPCR 
runs. As all cDNA samples were diluted the effect of potentially PCR inhibitory substances is 
reduced (Kubista et al. 2006). A non template control (NTC) and a between plate control 
(BPC), were included to detect contamination in mastermix and water, and to detect variations 
Methodological considerations                                                                           
 
 
78 
 
between plates, respectively. No signal was observed in NTC control. The standard deviation 
of BPC for each gene was as follows; EF1α: 0.21, GRLN-1: 0.35, GRLN-2: 0.56, PYY: 0.49, 
CCK-L: 0.52 and CCK-N: 0.54.  
The eukaryotic elongation factor 1α (EF1α) was included in the qPCR reaction as an 
endogenous control to compensate for intra- and inter-kinetic qPCR variations (Pfaffl 2004). 
Since the GI tract exists of several segments extracted from different individuals, normalizing 
the data against a constantly expressed reference gene may adjust for some of these 
differences. EF1α have been tested as a candidate reference gene in Atlantic salmon and 
shown to be a suitable choice (Olsvik et al. 2005). 
6.1.6 Quantification 
In this study absolute quantification was used. This quantification strategy relates 
qPCR signal (Ct value) to input copy number using an external calibration curve (Pfaffl 
2004). Although this method produces highly specific, sensitive and reproducible data (Bustin 
2000), the accuracy of absolute quantification in qPCR depends entirely on the accuracy of 
the standards (Pfaffl 2004). External calibration curves can be generated from recombinant 
RNA (recRNA) and recombinant DNA (recDNA) (Pfaffl and Hageleit 2001). Pfaffl et al. 
(2001) suggest that using recDNA calibration provides a better model than recRNA in 
quantifying mRNA, in terms of quantitative range, sensitivity, reproducibility and stability. 
The standards used for all assays were produced from recDNA by Dr. Koji Murashita 
(Murashita et al. 2009).  
RecDNA does not undergo reverse transcription like the mRNA samples, thus 
variability of the qPCR results and amplification results may lead to difficulties when 
comparing results from the tested sample (Pfaffl 2004). CDNA efficiency was monitored as a 
function of input total RNA and linear regression performed (Appendix III, Figure A.III.1). 
This is important as the recDNA calibration curve model only measures the cDNA out of RT 
reaction, and this may not reflect the mRNA molecules in the native sample. The linear 
regression, r
2
 value was 0.935, indicating a linear relationship between Ct and input RNA, but 
with a certain deviation from of a perfectly linear relationship (approaching r
2
 = 1). This 
deviation could be caused by cDNA synthesis efficiency below 100 %, or inaccurate 
pipetting. In the current study, samples were run in parallels in cDNA synthesis which is 
thought to minimize the effect of suboptimal efficiency in RT reaction (Stahlberg et al. 2004).  
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6.2 Randomization 
All tissue samples were randomized across all segments when isolating RNA and 
during DNase treatment and cDNA synthesis. When running RNA integrity analysis, samples 
were randomized according to http://randomization.com. In q-PCR, samples were run 
chronologically according to sample id. On the q-PCR plate, each sample was loaded into the 
same well location for the various assays, thus minimizing the effect of well variation on 
individual samples. Pipetting was done by one operator, thus minimizing operator variability.  
6.3 Statistical methods 
In the present study, parametric tests were chosen over nonparametric tests.  The 
parametric tests make more assumptions than the nonparametric tests, but may give a more 
accurate and precise estimate, with the nonparametric tests requiring a larger sample size to 
achieve the same power (Walpole 2002). The underlying assumptions of parametric tests 
include random sampling from a normal distributed population, and equal variance between 
groups (Zar 1996). 
All samples were randomly sampled in this study as far as possible and for each level 
of analysis and sampling. When it comes to testing for normality, the Shapiro-wilks W test 
was chosen due to its good power (Zar 1996). The test has been shown to be robust even for 
small sample sizes with n < 20 (Shapiro and Wilk 1965). Since some groups mean deviated 
from normality, the data were log transformed. After this only a few groups failed the 
normality assumption (see Appendix III).  
In order to detect differences between means of unfed and fed fish groups at a given 
time point, a t test was used giving the two-tailed hypothesis:  
H0: µ1 ־ µ2 = 0 an HA: µ1 ־ µ2 ≠ 0. This parametric test is extremely robust despite non-
normality and heterogeneity of variance (Zar 1996).  
The assumption that samples come from a normally distributed population and show 
homogeneity of variance is true also for analysis of variance (ANOVA). Especially if n is 
equal for all groups (Zar 1996), as is the case for this study. The weaker non-parametric tests 
show lack in the robustness of normality and variance assumptions. For these reasons, 
ANOVA was the preferred choice.  
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When three or more samples are included in a group, the hypothesis that the samples 
came from a population with identical variances can be tested (Zar 1996). Due to its 
robustness against non-normality, Levene´s F-test was used to test for equality in variance 
(Zar 1996).  
In the current study statistical tests were at times run on mRNA expression data for 
three fish, which is a minimum number of individuals required for statistical analysis in 
several statistical tests. However, originally six fish were sampled at each time point of the 
experiment. The reason for the reduction in fish number was due to fish in fed fish group 
which had not eaten and had large gallbladders (and vice versa for unfed fish control), and 
consequently would have biased the results. In addition the aspects of running costs 
associated with q-PCR and time available during this thesis limits the number of fish in each 
time group. 
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Appendix I  
Applied equipment 
 
Bio freezer: Forma ULT – 86 C Freezer (Thermo Scientific, USA) 
Scale: Mettler AC88 DeltaRange® (Mettler Toledo AS, Switzerland) 
Centrifuge: Eppendorf Centrifuge 5415R (Heracus Instruments, Germany) 
Tissue homogenizer: FastPrep™ FP120, BIO101 ThermoSavant  (Q-BIOgene, USA) 
Vortex: Test Tube Shaker (Wilmington, USA) 
Heat block: Techne DRI-BLOCK, DB-3D (Techne, USA) and VWR™ Digital Heatblock 
(Henry Troemner LLC, USA) 
PCR machine: Gene Amp PCR systems 2700 (ABI, USA) 
Real-Time RT-PCR machine: Chromo4™ Continuous Fluorescence Detector (Bio-Rad, 
Hercules, CA, USA) 
Spectrophotometer:  NanoDrop ND-1000 (Thermo Scientific, USA) 
Electrophoresis equipment: Agilent 2100 Bioanalyzer (Agilent Technologies, USA) 
Pipettes: PipetMan (Gilson, France) 
Pipette tips: Gilson Diamond® Filter tips (Gilson, France) 
Vials:  1.5ml Microcentrifuge tubes (Axygen, USA) and 0.6 ml PCR tubes (Axygen, USA) 
qPCR plates: Hard-Shell Thin-Wall 96-Well Skirted PCR Plates 
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Applied chemicals 
 
TRI-Reagent®: Batch # 087K0752 (Sigma, USA) 
Chloroform: Batch # 055K0070 (Sigma, USA) 
Isopropanol: Batch # 103K3724 (Sigma, USA) 
Nuclease-Free Water: Lot # 0809008 (Ambion, USA) 
Ethanol: 1000 ml Absolutt Prima (Arcus, Norway) 
Sodium Acetate: 3 M NaAc pH (5.5), Lot # 0708003, (Ambion, USA) 
DNase kit: TURBO DNA-free Kit™, Lot # 0809014, (Ambion, USA) 
Reverse transcription kit: Superscript III First-Strand Synthesis System, Lot # 495661 
(Invitrogen, USA) 
Primer for cDNA synthesis: Oligo(dT) (Sigma, USA) 
Real-time qPCR mastermix: Power SYBR
®
 Green PCR Master Mix (Applied Biosystems), 
Lot # 0902071 
RNA integrity kit: RNA 6000 Pico LabChip kit (Agilent Technologies, USA), Lot # 
MB18BK04 
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Appendix II 
Standard curves used in calculation of mRNA copy numbers 
 
 
 
Figure A.II.1: Standard calibration curve for GRLN-1. The GRLN-1 standard curve is constructed 
with serial 10-fold dilutions of GRLN-1 (recDNA), ranging from 1 x 10
2 
to 1 x 10
10
 (copies/ul). Each 
standard dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and 
plotted against the logarithm of their initial copy numbers. A linear regression through these point 
results in a standard curve with: y = -3.9685x + 43.512, R
2
 = 0.9984. 
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Figure A.II.2: Standard calibration curve for GRLN-2. The GRLN-2 standard curve is constructed 
with serial 10-fold dilutions of GRLN-2 (recDNA), ranging from 1 x 10
2 
to 1 x 10
10
 (copies/ul). Each 
standard dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and 
plotted against the logarithm of their initial copy numbers. A linear regression through these point 
results in a standard curve with: y = -3.8163x + 41.066, R
2
 = 0.9972. 
 
Figure A.II.3: Standard calibration curve for PYY. The PYY standard curve is constructed with 
serial 10-fold dilutions of PYY (recDNA), ranging from 1 x 10
2 
to 1 x 10
10
 (copies/ul). Each standard 
dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and plotted 
against the logarithm of their initial copy numbers. A linear regression through these point results in a 
standard curve with: y = -3.9685x + 43.512, R
2
 = 0.9984. 
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Figure A.II.4: Standard calibration curve for CCK-L. The CCK-L standard curve is constructed 
with serial 10-fold dilutions of CCK-L (recDNA), ranging from 1 x 10
2 
to 1 x 10
10
 (copies/ul). Each 
standard dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and 
plotted against the logarithm of their initial copy numbers. A linear regression through these point 
results in a standard curve with: y = -3.7811x + 42.463, R
2
 = 0.9965. 
 
Figure A.II.5: Standard calibration curve for CCK-N. The CCK-N standard curve is constructed 
with serial 10-fold dilutions of CCK-N (recDNA), ranging from 1 x 10
2 
to 1 x 10
10
 (copies/ul). Each 
standard dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and 
plotted against the logarithm of their initial copy numbers. A linear regression through these point 
results in a standard curve with: y = -3.5341x + 39.012, R
2
 = 0.9992. 
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Figure A.II.6: Standard calibration curve for EF1α. The EF1α standard curve is constructed with 
serial 10-fold dilutions of EF1α (recDNA), ranging from 1 x 103 to 1 x 1010 (copies/ul). Each standard 
dilution was run in duplicate reactions in qPCR. Determined Ct values were averaged and plotted 
against the logarithm of their initial copy numbers. A linear regression through these point results in a 
standard curve with: y = -3.7621x + 41.102, R
2
 = 0.995. 
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Appendix III 
Statistics 
Testing of normality 
Table A.III.1: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
unfed fish, segment 2 (stomach). W=1 if data are perfectly normal in distribution. Underlined and 
bold W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis.  
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0h W = 0.861 W = 0.902 W = 0.989 W = 0.973 W = 0.946 
Time 0.5h W = 0.991 W = 0.795 W = 0.999 W = 0.944 W = 0.948 
Time 1.5h W = 0.984 W = 0.993 W = 0.864 W = 0.953 W = 0.820 
Time 3h W = 0.795 W = 0.970 W = 0.785 W = 0.753 W = 0.953 
Time 6h W = 0.982 W = 1 W = 0.928 W = 0.970 W = 0.941 
Time 24h W = 0.855 W = 0.831 W = 0.972 W = 0.860 W = 0.970 
 
Table A.III.2: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
unfed fish, segment 4 (pyloric cecae). W=1 if data are perfectly normal in distribution. Underlined 
and bold W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal 
distribution hypothesis. 
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0h W = 0.944 W = 0.891 W = 0.787 W = 1 W = 0.980 
Time 0.5h W = 0.986 W = 0.772 W = 0.967 W = 0.960 W = 0.997 
Time 1.5h W = 0.924 W = 0.885 W = 0.777 W = 0.868 W = 0.965 
Time 3h W = 0.962 W = 0.968 W = 0.777 W = 0.941 W = 0.991 
Time 6h W = 0.959 W = 0.983 W = 0.893 W = 0.977 W = 0.991 
Time 24h W = 0.973 W = 0.879 W = 0.898 W = 0.918 W = 0.874 
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Table A.III.3: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
unfed fish, segment 6 (midgut). W=1 if data are perfectly normal in distribution. Underlined and bold 
W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0h W = 0.869 W = 0.890 W = 0.973 W = 0.873 W = - 
Time 0.5h W = 0.977 W = 0.992 W = 0.776 W = 0.963 W = - 
Time 1.5h W = 0.964 W = 0.996 W = 0.880 W = 0.844 W = - 
Time 3h W = 0.988 W = 0.998 W = 0.982 W = 0.912 W = - 
Time 6h W = 0.863 W = 0.791 W = 0.992 W = 0.871 W = - 
Time 24h W = 0.853 W = 0.988 W = 0.996 W = 0.818 W = - 
 
 
Table A.III.4: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
unfed fish, segment 9 (hindgut). W=1 if data are perfectly normal in distribution. Underlined and bold 
W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0h W = 0.826 W = 0.839 W = 0.789 W = 0.801 W = - 
Time 0.5h W = 0.956 W = 0.955 W = 0.906 W = 0.842 W = - 
Time 1.5h W = 0.983 W = 1 W = 0.954 W = 0.765 W = - 
Time 3h W = 0.992 W = 0.993 W = 0.833 W = 0.888 W = - 
Time 6h W = 0.784 W = 0.962 W = 0.883 W = 0.763 W = - 
Time 24h W = 0.923 W = 0.926 W = 0.992 W = 0.962 W = - 
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Table A.III.5: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
fed fish, segment 2 (stomach). W=1 if data are perfectly normal in distribution. Underlined and bold 
W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 
 
GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0.5h W = 0.982 W = 0.910 W = 0.910 W = 0.997 W = 0.865 
Time 1.5h W = 0.995 W = 0.928 W = 0.900 W = 0.985 W = 0.987 
Time 3h W = 0.752 W = 0.807 W = 0.961 W = 0.985 W = 0.835 
Time 6h W = 0.998 W = 0.754 W = 0.906 W = 0.995 W = 0.840 
Time 24h W = 0.865 W = 0.924 W = 0.757 W = 0.861 W = 0.863 
 
 
Table A.III.6: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
fed fish, segment 4 (pyloric cecae). W=1 if data are perfectly normal in distribution. Underlined and 
bold W values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0.5h W = 0.978 W = 0.972 W = 0.824 W = 0.953 W = 0.996 
Time 1.5h W = 0.871 W = 0.902 W = 0.990 W = 0.773 W = 0.969 
Time 3h W = 0.845 W = 0.754 W = 0.871 W = 0.979 W = 0.923 
Time 6h W = 0.954 W = 0.945 W = 0.975 W = 0.958 W = 0.996 
Time 24h W = 0.976 W = 0.976 W = 0.855 W = 0.910 W = 0.975 
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Table A.III.7: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
fed fish, segment 6 (midgut). W=1 if data are perfectly normal in distribution. Underlined and bold W 
values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0.5h W = 0.988 W = 0.999 W = 0.999 W = 0.915 W = - 
Time 1.5h W = 0.998 W = 0.866 W = 0.915 W = 0.970 W = - 
Time 3h W = 0.997 W = 1 W = 0.906 W = 0.979 W = - 
Time 6h W = 0.930 W = 0.883 W = 0.810 W = 0.850 W = - 
Time 24h W = 0.994 W = 0.982 W = 0.985 W = 0.944 W = - 
      
 
 
Table A.III.8: Shapiro-Wilks test of goodness of fit on log transformed normalized expression data for 
fed fish, segment 9 (hindgut). W=1 if data are perfectly normal in distribution. Underlined and bold W 
values are significantly smaller than 1 (p<0.05), indicating rejection of the normal distribution 
hypothesis. 
 
 
GRLN-1 GRLN-2 PYY CCK-L CCK-N 
Time 0.5h W = 0.984 W = 0.983 W = 0.804 W = 0.998 W = - 
Time 1.5h W = 1 W = 0.829 W = 0.753 W = 0.965 W = - 
Time 3h W = 1 W = 0.941 W = 0.798 W = 0.919 W = - 
Time 6h W = 0.857 W = 0.837 W = 0.922 W = 0.805 W = - 
Time 24h W = 0.955 W = 0.996 W = 0.995 W = 0.863 W = - 
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Tissue distribution of GRLN-1, GRLN-2, PYY, CCK-L and CCK-N mRNA in Atlantic 
salmon GIT: Factorial ANOVA results 
Table A.III.9: Factorial ANOVA of GRLN-1 mRNA tissue distribution in stomach, pyloric 
cecae, midgut and hindgut (segments ) of unfed and fed (group) Atlantic salmon 
  SS DF MS F p 
Intercept 126.977 1 126.977 2637.796 <<0.001 
Segment 19.460 3 6.487 134.749 <<0.001 
group 0.129 1 0.129 2.680 0.104 
Segment*group 0.037 3 0.012 0.255 0.858 
Error 5.969 124 0.048     
 
Table A.III.10:Factorial ANOVA of GRLN-2 mRNA tissue distribution in stomach, 
pyloric cecae, midgut and hindgut (segments ) of unfed and fed (group) Atlantic salmon 
 
SS DF MS F p 
Intercept 151.6494 1 151.6494 2831.984 <<0.001 
Segment 30.7324 3 10.2441 191.305 <<0.001 
group 0.4021 1 0.4021 7.508 <0.01 
Segment*group 0.1181 3 0.0394 0.735 0.533 
Error 6.6401 124 0.0535 
  
       
Table A.III.11:Factorial ANOVA of PYY mRNA tissue distribution in stomach, pyloric 
cecae, midgut and hindgut (segments ) of unfed and fed (group) Atlantic salmon 
  SS DF MS F p 
Intercept 1172.915 1 1172.915 29094.31 <<0.001 
Segment 25.856 3 8.619 213.78 <<0.001 
group 0.072 1 0.072 1.79 0.183 
Segment*group 0.402 3 0.134 3.32 <0.05 
Error 4.999 124 0.040 
  
 
Table A.III.12:Factorial ANOVA of CCK-L  mRNA tissue distribution in stomach, pyloric 
cecae, midgut and hindgut (segments ) of unfed and fed (group) Atlantic salmon 
 
SS DF MS F p 
Intercept 1591.657 1 1591.657 60158.325 <<0.001 
Segment 26.644 3 8.881 335.680 <<0.001 
group 0.000 1 0.000 0.001 0.975 
Segment*group 0.447 3 0.149 5.629 <0.01 
Error 3.281 124 0.026 
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Table A.III.13: Factorial ANOVA of CCK-N mRNA tissue distribution in stomach, pyloric 
cecae, midgut and hindgut (segments ) of unfed and fed (group) Atlantic salmon 
 
SS DF MS F p 
Intercept 908.096 1 908.096 6744.100 <<0.001 
Segment 0.013 1 0.013 0.096 0.758 
Group 0.381 1 0.381 2.829 0.098 
Segment*Group 0.178 1 0.178 1.320 0.255 
Error 8.348 62 0.135     
 
Tukey HSD post-hoc test results: 
Table A.III.14: Tukey HSD test results for log transformed GRLN-1 mRNA data in stomach (S2), 
pyloric cecae (S4), midgut (S6) and hindgut (S9) for unfed and fed fish. Non significant p values are 
listed as n.s. 
Error: Between MS = 0.04814, df = 124.00 
Cell 
No. 
Segment 
(S) 
group {1} {2} {3} {4} {5} {6} {7} {8}   
1   2 Unfed fish  n.s <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
2 2 Fed fish n.s  <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
3 4 Unfed fish <<0.001 <<0.00
1 
 n.s n.s n.s <<0.0
01 
<<0.0
01 
  
4 4 Fed fish <<0.001 <<0.00
1 
n.s  n.s n.s <<0.0
01 
<<0.0
01 
  
5 6 Unfed fish <<0.001 <<0.00
1 
n.s n.s  n.s <<0.0
01 
<0.05   
6 6 Fed fish <<0.001 <<0.00
1 
n.s n.s n.s  <<0.0
01 
<<0.0
01 
  
7 9 Unfed fish <<0.001 <<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
 n.s   
8 9 Fed fish <<0.001 <<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
n.s    
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Table A.III.15: Tukey HSD test results for log transformed GRLN-2 mRNA data in stomach (S2), 
pyloric cecae (S4), midgut (S6) and hindgut (S9) for unfed and fed fish. Non significant p values are 
listed as n.s. 
Error: Between MS = ,03617, df = 124,00 
Cell No. Segmen
t (S) 
group {1} {2} {3} {4} {5} {6} {7} {8}   
1 2 Unfed 
fish 
 n.s <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
2 2 Fed fish n.s  <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
3 4 Unfed 
fish 
<<0.0
01 
<<0.00
1 
 n.s n.s n.s <<0.0
01 
<<0.0
01 
  
4 4 Fed fish <<0.0
01 
<<0.00
1 
n.s  n.s n.s <<0.0
01 
<<0.0
01 
  
5 6 Unfed 
fish 
<<0.0
01 
<<0.00
1 
n.s n.s  n.s <<0.0
01 
<<0.0
01 
  
6 6 Fed fish <<0.0
01 
<<0.00
1 
n.s n.s n.s  <<0.0
01 
<<0.0
01 
  
7 9 Unfed 
fish 
<<0.0
01 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
 n.s   
8 9 Fed fish <<0.0
01 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
n.s    
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Table A.III.16: Tukey HSD test results for log transformed PYY mRNA data in stomach (S2), pyloric 
cecae (S4), midgut (S6) and hindgut (S9) for unfed and fed fish. Non significant p values are listed as 
n.s. 
Error: Between MS = ,04031, df = 124,00 
Cell 
No. 
Segment 
(S) 
group {1} {2} {3} {4} {5} {6} {7} {8}   
1 2 Unfed fish  <0.05 <<0.00
1 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
2 2 Fed fish <0.05  <<0.00
1 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
3 4 Unfed fish <<0.0
01 
<<0.00
1 
 n.s n.s n.s <<0.0
01 
<<0.0
01 
  
4 4 Fed fish <<0.0
01 
<<0.00
1 
n.s  n.s n.s <<0.0
01 
<<0.0
01 
  
5 6 Unfed fish <<0.0
01 
<<0.00
1 
n.s n.s  n.s <<0.0
01 
<<0.0
01 
  
6 6 Fed fish <<0.0
01 
<<0.00
1 
n.s n.s n.s  <<0.0
01 
<<0.0
01 
  
7 9 Unfed fish <<0.0
01 
<<0.00
1 
<<0.00
1 
<<0.00
1 
<<0.0
01 
<<0.0
01 
 n.s   
8 9 Fed fish <<0.0
01 
<<0.00
1 
<<0.00
1 
<<0.00
1 
<<0.0
01 
<<0.0
01 
n.s    
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Table A.III.18: Tukey HSD test results for log transformed CCK-L mRNA data in stomach (S2), 
pyloric cecae (S4), midgut (S6) and hindgut (S9) for unfed and fed fish. Non significant p values are 
listed as n.s. 
Error: Between MS = ,02646, df = 124,00 
Cell No. Segm
ent 
(S) 
group {1} {2} {3} {4} {5} {6} {7} {8}   
1 2 Unfed fish  0,059 <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
2 2 Fed fish 0,059  <<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
  
3 4 Unfed fish <<0.0
01 
<<0.00
1 
 n.s n.s n.s <<0.0
01 
<<0.0
01 
  
4 4 Fed fish <<0.0
01 
<<0.00
1 
n.s  <0.01 n.s <<0.0
01 
<<0.0
01 
  
5 6 Unfed fish <<0.0
01 
<<0.00
1 
n.s <0.01  n.s <<0.0
01 
<<0.0
01 
  
6 6 Fed fish <<0.0
01 
<<0.00
1 
n.s n.s n.s  <<0.0
01 
<<0.0
01 
  
7 9 Unfed fish <<0.0
01 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
 n.s   
8 9 Fed fish <<0.0
01 
<<0.00
1 
<<0.0
01 
<<0.0
01 
<<0.0
01 
<<0.0
01 
n.s    
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Postprandial effect on mRNA expression of GRLN-1, GRLN-2, PYY, CCK-L and CCK-
N in Atlantic salmon GIT: Main effect ANOVA 
Main effects ANOVA 
Table A.III.19: Main effects ANOVA for log transformed CCK-L copy no in segment 
2 (stomach) of Atlantic salmon with time (h) and fish groups (unfed/fed) as effects. Non 
significant values are listed as n.s. 
Effect SS DF MS F p 
Intercept 534.770 1 534.770 27135.926 <<0.001 
Time: 0.029 5 0.006 0.299 n.s 
Group 0.206 1 0.202 10.477 <0.01 
Error 0.512 26 0.020     
 
Table A.III.20: Main effects ANOVA for log transformed CCK-L copy no in segment 
4 (pyloric cecae) of Atlantic salmon with time (h) and fish groups (unfed/fed) as effects. 
Non significant values are listed as n.s. 
 
SS DF MS F p 
Intercept 335.970 1 335.870 5824.966 <<0.001 
Time 0.804 5 0.161 2.787 <0.05 
Group 0.013 1 0.013 0.226 n.s 
Error 1.500 26 0.058     
 
Table A.III.21: Main effects ANOVA for log transformed GRLN-2 copy no in segment 
6 (midgut) of Atlantic salmon with time (h) and fish groups (unfed/fed) as effects. Non 
significant values are listed as n.s. 
Effect SS DF MS F p 
Intercept 36.700 1 36.700 850.468 <<0.001 
Time: 0.164 5 0.033 0.761 n.s 
Group 0.247 1 0.247 5.716 <0.05 
Error 1.122 26 0.043     
 
Table A.III.22: Main effects ANOVA for log transformed PYY copy no in segment 6 
(midgut) of Atlantic salmon with time time (h) and fish groups (unfed/fed) as effects. 
Non significant values are listed as n.s. 
Effect SS DF MS F p 
Intercept 201.484 1 201.484 173407.129 <<0.001 
Time: 0.016 5 0.003 2.780 <0.05 
Group 0 1 0 0.099 n.s 
Error 0.030 26 0.001     
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Table A.III.23: Main effects ANOVA for log transformed CCK-L copy no in segment 
6 (midgut) of Atlantic salmon with time (h) and fish groups (unfed/fed) as effects. Non 
significant values are listed as n.s. 
Effect SS DF MS F p 
Intercept 349.819 1 349.819 48114.319 <<0.001 
Time: 0.054 5 0.011 1.498 n.s 
Group 0.063 1 0.063 8.691 <0.01 
Error 0.189 26 0.007     
 
 
Tukey HSD post hoc tests for significant values in main effects ANOVA 
Table A.III.24: Tukey HSD test for log transformed 
CCK-L copy no data in segment 2 (somach) of Atlantic 
salmon 
Cell No. Group {1} {2} 
1 Unfed fish 
 
<0.01 
2 Fed fish <0.01   
 
Table A.III.25: Tukey HSD test for log transformed CCK-L copy no in segment 4 (pyloric cecae) with 
time as main effect. Non significant values are listed as n.s. 
Cell No. Time: {1} {2} {3} {4} {5} {6} 
1 0   <0.05 n.s n.s n.s <0.05 
2 0,5 <0.05 
 
n.s n.s n.s n.s 
3 1,5 n.s n.s 
 
n.s n.s n.s 
4 3 n.s n.s n.s 
 
n.s n.s 
5 6 n.s n.s n.s n.s 
 
n.s 
6 24 <0.05 n.s n.s n.s n.s   
 
Table A.III.26: Tukey HSD test for log transformed 
GRLN-2 copy no data in segment 6 (midgut) of Atlantic 
salmon 
Cell No. Group {1} {2} 
1 Unfed fish   <0.05 
2 Fed fish <0.05   
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Table A.III.27: Tukey HSD test for log transformed PYY copy no in segment 6 (midgut) of 
Atlantic salmon. Non significant values are listed as n.s.   
Cell No. Time: {1} {2} {3} {4} {5} {6} 
1 0   <0.05 n.s n.s n.s n.s 
2 0,5 <0.05 
 
n.s n.s n.s n.s 
3 1,5 n.s n.s 
 
n.s n.s n.s 
4 3 n.s n.s n.s 
 
n.s n.s 
5 6 n.s n.s n.s n.s 
 
n.s 
6 24 n.s n.s n.s n.s n.s   
 
Table A.III.28: Tukey HSD test for log transformed 
CCK-L copy no data in segment 6 (midgut) of Atlantic 
salmon 
Cell No. Group {1} {2} 
1 Fasted fish   <0.01 
2 Fed fish <0.01   
 
 
Postprandial effect on GRLN-1, GRLN-2, PYY, CCK-L and CCK-N mRNA expression: 
T-test results 
Table A.III.29: T-test of log transformed GRLN-1 mRNA normalized expression in S6 at time:=24. 
Groups were treated as independent samples. Group 1=Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 
Mean group 
2 
t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-1.088 -0.852 -13.535 4 <<0.001 0.029 0.010 
 
Table A.III.30: T-test of log transformed GRLN-1 mRNA normalized expression in S9 at time:=24. 
Groups were treated as independent samples. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-1.483 -1.115 -7.078 4 <0.01 0.052 0.074 
 
Table A.III.31: T-test of log transformed GRLN-2 mRNA normalized expression in S6 at time:=24. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-1.178 -0.846 -6.515 4 <0.01 0.078 0.042 
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Table A.III.32: T-test of log transformed GRLN-2 mRNA normalized expression in S9 at time:=24. 
Groups were treated as independent samples. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 
Mean group 
2 
t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-1.851 -1.312 -9.558 4 <<0.001 0.065 0.073 
 
Table A.III.33: T-test of log transformed PYY mRNA normalized expression in S9 at time:=1.5. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-3.036 -2.916 -4.210 4 <0.05 0.048 0.013 
 
Table A.III.34: T-test of log transformed PYY mRNA normalized expression in S9 at time:=3. Groups 
were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-2.917 -3.084 4.059 4 <0.05 0.062 0.036 
 
Table A.III.35: T-test of log transformed PYY mRNA normalized expression in S9 at time:=24. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-2.957 -3.004 3.100 4 <0.05 0.024 0.011 
 
Table A.III.36: T-test of log transformed CCK-L mRNA normalized expression in S2 at time:=3. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-4.102 -4.397 2.900 4 <0.05 0.112 0.135 
 
Table A.III.37: T-test of log transformed CCK-L mRNA normalized expression in S6 at time:=0.5. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-3.558 -3.362 -4.996 4 <0.01 0.014 0.067 
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Table A.III.38: T-test of log transformed CCK-L mRNA normalized expression in S6 at time:=24. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-3.450 -3.267 -3.270 4 <0.05 0.095 0.017 
 
Table A.III.39: T-test of log transformed CCK-L mRNA normalized expression in S9 at time:=1.5. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-2.959 -3.018 2.906 4 <0.05 0.033 0.013 
 
Table A.III.40: T-test of log transformed CCK-N mRNA normalized expression in S2 at time:=1.5. 
Groups were treated as independent variables. Group 1= Unfed fish (n=3), Group 2=Fed fish (n=3). 
 
Mean group 1 Mean group 2 t-value df p 
Std.Dev. 
Group 1 
Std.Dev. 
Group 2 
Fasted fish: 
vs. Fed fish: 
-4.115 -3.406 -2.846 4 <0.05 0.423 0.087 
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cDNA synthesis efficiency 
 
Figure A.III.1 cDNA synthesis efficiency. Data are represented as qPCR Ct values (y-axis) of 
a random gene (GRLN-1) plotted against the logarithm of a standard dilution series of RNA 
from 12 random samples into cDNA synthesis (x-axis).  The four different dilutions (D1-D4) 
were run in parallel reactions into reverse transcription (RT) reaction with the following 
amount of total RNA (estimated with Nanodrop):  D1=5000 ng, D2=2500 ng, D3=1250 ng 
and D4=625 ng. The qPCR reaction gave the following Ct values ±SD(standard deviation): 
D1=24.47±0.35, D2=24.81±0.01, D3=25.64±0.08 and D4=26.70±0.14. The slope of the RNA 
dilution curve was calculated by linear regression: y = -2.508x + 33.56 and the coefficient of 
determination (r²) = 0.935.  
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RNA integrity assessment  
 
Figure A.III.2: RNA integrity numbers (RIN) for different segments in Atlantic salmon GI 
tract. The y-axis show RIN categories 1 to 10, where 10 is a fully intact sample and 1 is a 
totally degraded sample. The x-axis show the mean combined results for unfed and fed fish 
groups in different segments of the GI tract, including stomach tissue (Segment 2); n=32, 
pyloric cecae (Segment 4); n=32, midgut (Segment 6); n=33 and hindgut (Segment 9); n=32. 
Error bars express ±SD.  
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Linear regression of Ct against RIN 
 
Figure A.III.3: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
stomach tissue of Atlantic salmon (segment 2). The results are represented as average Ct of two 
parallels from q-PCR absolute expression for EF1a reference gene (n=32), GRLN-1 (n= 32) and 
GRLN-2 (n=32). The linear regression lines show the following values; EF1a: y = -0.239x + 18.39, 
GRLN-1: y = -0.370x + 26.76 and GRLN-2: y = -0.341x + 24.53. The r
2
 and p values of regression are 
shown in Table 3.4.  
 
Figure A.III.4: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
stomach tissue of Atlantic salmon (segment 2). The results are represented as average Ct of two 
parallels from q-PCR absolute expression for PYY (n= 32), CCK-L (n= 32) and CCK-N (n= 32). The 
linear regression lines show the following values; PYY: y = 1.081x + 19.99, CCK-L: y = -0.025x + 
35.88 and CCK-N: y = -0.188x + 31.66. The r
2
 and p values of regression are shown in Table 3.4. 
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Figure A.III.5: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
pyloric cecae tissue of Atlantic salmon (segment 4). The results are represented as average Ct of two 
parallels from qPCR absolute expression for EF1a reference gene (n= 32), GRLN-1 (n=32 ) and 
GRLN-2 (n= 32). The linear regression lines show the following values; EF1a: y = -0.795x + 22.53, 
GRLN-1: y = -1.242x + 39.42 and GRLN-2: y = -1.233x + 38.12. The r
2
 and p values of regression are 
shown in Table 3.4. 
 
 
Figure A.III.6: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
pyloric cecae tissue of Atlantic salmon (segment 4). The results are represented as average Ct of two 
parallels from qPCR absolute expression for PYY (n= 32), CCK-L (n= 32) and CCK-N (n= 32). The 
linear regression lines show the following values; PYY: y = -1.101x + 28.44, CCK-L: y = -1.714x + 
42.03 and CCK-N: y = -1.933x + 43.64. The r
2
 and p values of regression are shown in Table 3.4.  
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Figure A.III.7: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
midgut tissue of Atlantic salmon (segment 6). The results are represented as average Ct of two 
parallels from qPCR absolute expression for EF1a reference gene (n= 33), GRLN-1 (n= 33) and 
GRLN-2 (n=33). The linear regression lines show the following values; EF1a: y = -0495x + 21.07, 
GRLN-1: y = -0.080x + 32.15 and GRLN-2: y = 0.362x + 27.04. The r
2
 and p values of regression are 
shown in Table 3.4. 
 
 
Figure A.III.8: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
midgut tissue of Atlantic salmon (segment 4). The results are represented as average Ct of two 
parallels from qPCR absolute expression for PYY (n= 33), CCK-L (n= 33) and CCK-N (n= 33). The 
linear regression lines show the following values; PYY: y = -0.372x + 22.93, CCK-L: y = -0.004x + 
31.25 and CCK-N: y = -0.922x + 43.77. The r
2
 and p values of regression are shown in Table 3.4. 
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Figure A.III.9: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
hindgut tissue of Atlantic salmon (segment 9). The results are represented as average Ct of two 
parallels from qPCR absolute expression for EF1a reference gene (n= 32), GRLN-1 (n=32) and 
GRLN-2 (n=32). The linear regression lines show the following values; EF1a: y = -0.269x + 19.93, 
GRLN-1: y = -0.446x + 37.76 and GRLN-2: y = -0.530x + 37.78. The r
2
 and p values of regression are 
shown in Table 3.4. 
 
Figure A.III.10: Correlation between cycle threshold value (Ct) and RNA integrity number (RIN) in 
hindgut tissue of Atlantic salmon (segment 9). The results are represented as average Ct of two 
parallels from qPCR absolute expression for PYY (n= 32), CCK-L (n= 32) and CCK-N (n= 32). The 
linear regression lines show the following values; PYY: y = -0.205x + 26.56, CCK-L: y = -0.478x + 
31.53 and CCK-N: y = -0.374x + 40.80. The r
2
 and p values of regression are shown in Table 3.4. 
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Postprandial effects and tissue distribution of EF1α  
 
 
Figure A.III.11: EF1a expression in Atlantic salmon gut tissue. Data are presented as mean (n=3) 
calculated copy number (±S.D) for fasted fish (black square) and fed fish (red triangle) at time (h); 
0.5, 1.5, 3, 6 and 24. Time 0 is represented for fasted fish only, as this marks the start of the 
experiment. a) Represents results for stomach tissue (S2), b) represents results for pyloric cecae (S4), 
c) represents result for midgut (S6) and d) represents result for hindgut (S9).  Mean values with an 
asterisk above show significant differences between fish groups at a given time point (p<0.5). 
 
 
(a)
0 3 6 9 12 15 18 21 24
Time (h)
34
36
38
40
42
E
F
1
a
 e
x
p
re
s
s
io
n
(b)
0 3 6 9 12 15 18 21 24
 Time (h)
34
36
38
40
42
E
F
1
a
 e
x
p
re
s
s
io
n
(c)
0 3 6 9 12 15 18 21 24
Time (h)
34
36
38
40
42
E
F
1
a
 e
x
p
re
s
s
io
n
(d)
0 3 6 9 12 15 18 21 24
Time (h)
34
36
38
40
42
E
F
1
a
 e
x
p
re
s
s
io
n
 Fasted fish:
 Fed fish:
Appendix III                                                                          
 
 
120 
 
 
Figure A.III.12:  Segmental distribution of EF1a reference gene mRNA in Atlantic salmon GI tract. 
Data are represented as mean calculated copy number for fasted fish (n= 18), and fed fish (n= 15) ± 
SD, for stomach (S2), pyloric cecae (S4), midgut (S6) and hindgut (S9). 
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Appendix IV 
Composition of feed used in the postprandial experiment 
Table AIV1. Dietary ingredients, chemical composition and energy of the feed used. Values 
provided by the producer (EWOS, Norway). 
 
 EWOS Micro 50 
Ingredients (g kg
-1
)  
Fish meal 471 
Wheat 140 
Plant proteins 200 
Fish oil 185 
Premix (vitamin, minerals) 2 
  
Composition (g kg
-1
)  
Protein 48 
Fat 24 
Water 8 
Ash 8.5 
Fiber 1 
Extracts 12 
  
Gross energy (MJ kg
-1
) 22.9 
 
 
 
 
